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Background: HIV continues to be a pervasive public health issue in the United States with more 
than 1.2 million people living with HIV (PLWHIV) across the nation. Gay, bisexual and other 
men who have sex with men (GBM) account for over two-thirds of all new HIV diagnoses with 
racial and ethnic minorities shouldering a large proportion of the burden of disease. Although 
HIV transmission is predominantly driven by sexual behaviors, there are underlying complex 
individual, behavioral, and structural factors that contribute to high rates of sexual behavior and 
subsequent HIV acquisition. Moreover, difficulties remain in maximizing linkage to care and 
viral suppression for PLWHIV. Despite the wealth of research showing the importance of viral 
suppression as a tool for controlling the HIV epidemic, over one-quarter of HIV-positive GBM 
are not fully engaged in HIV primary medical care; Sexual minority populations of color 
experience starkly worse rates of engagement in HIV care. This multi-method dissertation aimed 
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to understand how multi-level factors compound HIV risk in a U.S. national sample of GBM and 
to describe engagement in HIV care among those newly diagnosed with HIV. The following 
specific aims were addressed: 
Aim 1: Measure exposure to syndemic conditions, describe the conditions most likely to co-
occur and examine their association to HIV risk.  
Aim 2: Describe the levels of resilience and identify associations with HIV risk and conduct 
comparisons by race/ethnicity, region, age and other socio-demographic characteristics. 
Aim 3: Describe the barriers and facilitators to engagement in prompt HIV care 3-months after 
the delivery of an HIV-positive result.  
Methods: Data for this study was collected as part of the Together 5,000 study, a U.S. national, 
internet-based cohort study of men, transgender men, and transgender women who have sex with 
men. For Aims 1 and 2, we conducted secondary analysis of quantitative survey data from a 
cohort of 6,118 GBM ages 16-49 at high risk for HIV transmission. The surveys gathered data on 
demographics, HIV risk behaviors, HIV and STI testing history, mental health, and interpersonal 
factors. For Aim 1, we evaluated the prevalence of syndemic conditions and explored their 
associations with HIV risk. Descriptive statistics were used to describe the sample and the 
prevalence of syndemic conditions. The associations were determined using adjusted multiple 
linear regressions. For Aim 2, we measured and described the sociodemographic differences in 
levels of resilience and explored the association between resilience and HIV risk. The 
associations were determined using adjusted multiple linear regressions. For aim 3, we 
conducted secondary analysis of qualitative in-depth interviews from 50 GBM diagnosed HIV-
positive during their participation in Together 5,000. The goal of Aim 3 was to described 
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participants experiences getting linked-to-care and identify barriers and facilitators to 
engagement in HIV care using thematic analysis.  
Results: In Aim 1 we found a high prevalence of intimate partner violence (IPV), experiences of 
childhood sexual abuse, homelessness and mental health issues. Further, IPV, depression, 
polydrug use, incarceration history and homelessness were positively associated with HIV risk. 
We also demonstrated that increasing cumulative syndemic conditions were associated with 
higher HIV risk. Those who reported 3 or more co-occurring conditions had the highest risk for 
HIV. In Aim 2, we found higher mean resilience scores among those identifying as black, with 
higher education, having full-time employment, higher incomes, and those who have health 
insurance. Although we found no statistically significant association between resilience and our 
composite measure of HIV risk, we did find a significant association between higher resilience 
and lower condomless receptive anal sex acts in the last 3 months. In Aim 3, we found that the 
majority of participants reported being linked-to-care, while only 74.5% of those reported 
initiating ART. Thematic analysis identified 4 major themes related to participants’ engagement 
in care: 1) Reasons for HIV testing (e.g., HIV self-testing and expectation of positivity), 2) 
Linkage-to-care (e.g., appointment/logistic issues and social support as encouragement), 3) 
Barriers (e.g., financial burden, competing priorities and fear/stigma) and facilitators (e.g., 
financial assistance, patient-provider relationships, auxiliary support services and health 
agency) to engagement in HIV care, and 4) PrEP as a missed prevention opportunity.  
Conclusion: Overall, the findings from this multi-method dissertation suggest that the HIV 
epidemic is complex, and therefore an effective response requires an understanding of the 
diversity and dynamic nature of individuals, communities, and our socio-political environment. 
We demonstrated that environmental and behavioral factors such as homelessness, incarceration 
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are prevalent among GBM in the U.S. and contribute to HIV acquisition, thus offering 
compelling evidence for the adoption of these variables in future syndemic models. Further, 
there needs to be a more comprehensive investigation of the unique risk factors in this 
population, particularly those that may impact uptake and adoption of preventive HIV health 
behaviors, such as pre-exposure prophylaxis (PrEP). For instance, larger structural factors like 
societal racial discrimination, anti-immigration laws, lack of health insurance coverage and 
unemployment can significantly impact adherence to biomedical tools and use of testing 
services. Future research should explore these social and structural determinants within the 
context of HIV prevention. There is a need for targeted interventions for those at the highest risk, 
particularly racial and ethnic minorities and those from impoverished communities to increase 
HIV testing frequency and facilitate better engagement in care. Further, as seen in our study 
findings, HIV prevention is a multi-faceted process. As such, there is a need for a more holistic 
approach to prevention, wherein HIV prevention is conceptualized as more than just HIV testing 
and PrEP initiation but that takes into account intrapersonal (e.g,, resilience) and interpersonal 
factors (e.g., social support). Finally, addressing policy-, social- and individual-level barriers 
could improve GBM’s engagement in HIV care. Capitalizing on GBM’s health agency through 
partnerships with local agencies and fostering better patient-provider relationships could 
optimize continuity of HIV care. We possess the tools needed to end the HIV epidemic in the 
U.S., particularly by advocating for a new federal policy which streamlines HIV testing, linkage-
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CHAPTER 1 – INTRODUCTION 
Background 
HIV continues to be a pervasive public health issue in the United States.1,2 To date, there 
are more than 1.2 million people living with HIV (PLWHIV) a)cross the nation (Figure 1.1).3-5 
Since the beginning of the epidemic, more than 700,000 people have died from HIV-related 
complications.3-6 As of 2015, the U.S. accounted for about 3.5% of the global burden of 
HIV.1,3,7,8 According to the UNAIDS definition, the HIV epidemic in the U.S. is classified as a 
concentrated epidemic given that the majority of infections occur in high-risk subpopulations.7,8 
As such, incidence rates have been adopted as the primary measure for the nation’s HIV 
response because they reflect the concentration of HIV diagnoses, accounting for population size 
across geographic boundaries, and are adequate for determining pockets of infectiousness.2,3,6,9,10 
Nationally, there are around 40,000 incident cases per year; gay, bisexual and other men who 
have sex with men (GBM) account for over two-thirds of all HIV diagnoses.1,3,11,12 
Technological advances in the efficacy of antiretroviral treatment (ART) have transformed the 
management of HIV from an emergency response to a devastating epidemic to efforts at chronic 
disease management.13-16 Given this, more people continue to live longer, healthier lives, and, 
therefore, the overall prevalence of HIV continues on an upward trajectory.1,3,4 
HIV and Gay, Bisexual and other Men who have sex with Men in the U.S. 
  The first cases of HIV/AIDS were identified among young gay men in the 1980s.17 
Although new infections peaked at about 130,000 cases per year in the late 80’s, the Centers for 
Disease Control and Prevention (CDC) recently estimated stabilizing incidence rates of about 
40,000 new annual HIV infections.11,12,18 In 1983, almost three-quarters (71%) of HIV 
transmissions were attributed to male-to-male sexual behavior. 6,10,19,20 The proportion of 
incident HIV among GBM declined to 44% in 1996, but later rebounded to a staggering 72% of 
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total transmissions in 2006.6,10,19,20 From 2012 to 2016, the number of new HIV infections 
remained relatively stable across the U.S. Nonetheless, the rate of HIV diagnoses varied 
geographically and across subpopulations, thus pointing to several risk pools.2,3,6,10 According to 
CDC surveillance data, the rate of HIV diagnoses was highest in the South (16.1 per 100,000 
people), followed by U.S. territories (12.3), including Guam and Puerto Rico, the Northeast 
(10.6), the West (9.4) and the Midwest (7.4).1,3,4,12,18 Young adults were found to be at 
concerning risk for HIV; individuals under the age of 35 accounted for 56% of all new HIV 
diagnoses in 2017 and those aged between 25 and 34 years accounted for 35%.3,4,12,18 Although 
new HIV diagnoses have been declining over the last decade, the number of incident cases of 
HIV among GBM has remained relatively stable (Figure 1.2).1,3,4,12,13,18,20 Notably, the 
proportion of HIV cases among GBM has been increasing slightly since 2011.1,3,4,12,13,18,20   
  Strikingly, the number of new infections among young GBM aged 13-24, increased 22% 
in 2010,1,3,18 and similar trends have been reported among young GBM living in urban centers, 
such as New York City (Figure 1.3).8,11,21 Although recent data points towards stabilizing HIV 
rates among black GBM, 1,3,18 they still remain the only at-risk group in the U.S. for which new 
HIV infections rates have resurged and shown few signs of reduction over the past decade. 
Furthermore, black and Latino GBM have a 1 in 2 and 1 in 4 chance, respectively, of becoming 
infected with HIV in their lifetime, thus warranting continued and concerted efforts for 
prevention and intervention in these populations.1,3,18 
 Racial and ethnic minorities were found to be disproportionately affected by the epidemic 
and represented a large proportion of new cases.3,4,6,10,12,18,22,23 Particularly, the HIV epidemic has 
been heavily concentrated among black and Latino GBM.24  Incident rates for African-American 
individuals were as high as 41.1 per 100,000 persons in 2016; comparable rates were 16.1 for 
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Hispanic/Latinos and 5.1 for Whites.1,3,4,13,25 Although initially an epidemic affecting 
predominantly white GBM, the racial, ethnic, and economic composition of PLWHIV has 
shifted dramatically over the last 30 years to one largely affecting economically disadvantaged 
sexual minorities of color.20,26-29  
HIV Risk Factors for GBM 
  Although HIV transmission is predominantly a factor of sexual behavior, there are 
underlying complex social, economic, and environmental factors that contribute to high rates of 
sexual behavior and HIV acquisition,22,30,31 particularly, stigma, discrimination, and 
poverty.22,30,31 Most of the literature has focused on condomless anal sex (CAS) as a risk factor 
for HIV. Moreover, attention has been paid to correlates of CAS, such as drug use (e.g., 
methamphetamines, cocaine, etc.), alcohol abuse, and poor mental health as important mediators 
of HIV transmission.32,33    Transmission risk behaviors among dyads or couples is of particular 
importance. Relationship characteristics, such as increased intimacy, inadequate communication 
skills and unstable power dynamics, have been found to lead higher rates of condom 
discontinuation (or lack of use) during couple’s sexual relationships.34-36 
  Sexual networks have been found to be an underlying driver of the epidemic. Larger 
sexual networks give GBM more opportunities for exposure. Studies have found a positive 
association between larger sexual networks and total number of sexual partners, CAS, substance 
use, and STI prevalence.37-40  Notably, homophily in sexual networks is presumed to be an 
important underlying and understudied factor impacting HIV rates among black GBM, 
particularly given this group’s already elevated risk.39 Further, rates of homelessness are 
especially high for young GBM and other gender non-conforming youth;41,42 in fact, such youth 
are at a heightened risk for engaging in survival sex work and, as such, are more likely to exhibit 
HIV risk behaviors with clients.42  
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  Stigma, racism, and marginalization have been identified as drivers of the epidemic. 
Research regarding the role of stigma on HIV risk in GBM has found that discrimination is often 
compounded with other sources of stigma, including stigma around gender identity and racism.43-
52 Gender roles have been shown to influence the perception that one male partner is “womanly” 
or “weak”, which in turn facilitates problematic power dynamics, such as when the more 
”manly” partner exerts undue influence over decisions surrounding condom use.43,44,52,53 This 
stigma produces marginalization in GBM and, in turn, strongly influences an individual’s 
vulnerability for HIV infection through engagement in higher risk sexual behaviors.44,46,47,53-55 
This is particularly true for individuals in disadvantaged social positions, who are likely to go 
through psychologically straining life experiences (stressors) due to their intersecting identities 
(e.g., being gay and black in a racist and sexist social environment).44,46,56-58  
  Legislation contributing to unequal access to preventive programming may act as a 
barrier to the HIV response. In particular, geographic disparities in HIV infection are not 
uncommon in the U.S., with the South having twice as many young adults diagnosed with an 
AIDS-related infection when compared to the northeast.59 Despite the expansion of Medicaid 
and the advent of the Affordable Care Act, the South is one of the more restrictive regions in the 
U.S. when it comes to Medicaid eligibility.59-61 This restrictiveness results in many PLWHIV 
being un- or under-insured, less likely to be virally suppressed, and more likely to contribute to 
forward transmission. Moreover, a recent CDC analysis found that black GBM living in the 
South are undertested despite being at higher risk for HIV, therefore pointing to a gap in service 
delivery.62 These multi-level mechanisms contribute and play a pivotal role in how GBM of 
color engage in, or fail to engage in, preventative services. These factors also highlight the need 
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to understand the intersecting nature of HIV risk, particularly among those from disadvantaged 
communities. 
Resilience as a buffer for HIV Risk 
Resilience is a multi-dimensional intrapersonal characteristic that positively influences 
self-efficacy and adaptive coping and has been thought to contribute to better health and 
decreased HIV risk through behavioral, psychological and physiological mechanisms.57,63 There 
is a growing body of literature that documents cross-sectional associations among greater levels 
of resilience, protective sexual behaviors (e.g., consistent condom use), and a lower HIV 
prevalence. A study of Black GBM in Texas found that social support, a resilience psychosocial 
factor, was positively associated with more frequent HIV testing and higher rates of consistent 
condom use during anal sex.64 Another study of Black GBM in southern states found that 
individuals with higher resilience scores had a lower prevalence of condomless sex.65 Another 
study saw a negative correlation between higher resilience and heavy substance use and mental 
health issues, and prevalent HIV infection.66  
 A resilience framework implies a departure from deficit-based research and could denote 
an opportunity to build on strength-based approaches to the public health response to HIV/AIDS. 
Resilience theory focuses on protective factors that originate at the individual level, such as 
coping, and translates to factual resources at the community level, such as social support. Herrick 
et al., describe how social support and high community involvement are associated with 
decreased risk behaviors and conclude that harnessing the strengths and resilience of GBM may 
enhance HIV prevention programs and, thus, reverse trends in infection.67-69 Nevertheless, most 
of the published literature on resilience remains largely theoretical and widely understudied in 
the HIV literature. 
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Ending the HIV Epidemic across the Nation 
The United States Department of Health and Human Services established The Ending the 
HIV Epidemic: A Plan for America (EHE) to reduce the number of new HIV infections by 75% 
by 2025 through combination efforts, including treatment as prevention, pre-exposure 
prophylaxis (PrEP), post-exposure prophylaxis (PEP), and HIV testing with timely linkage to 
care.9,70-72 Further, the UNAIDS “90-90-90” strategy calls for 90% of people living with HIV to 
be diagnosed, with 90% initiating ART, and 90% of people initiating ART to achieve and sustain 
viral suppression through adherence to the treatment and engagement in medical care.15 
Successful and prolonged engagement in HIV care, including ART, not only reduces HIV 
transmission and risk behaviors, but also leads to improvements in the morbidity and mortality of 
HIV- and AIDS-related illnesses, thus facilitating improvements in overall health.21,28,29  
Undetectable = Untransmittable   
  In 2015, the World Health Organization (WHO) revised its guidelines and recommended 
that anyone infected with HIV should begin antiretroviral therapy (ART) as soon after diagnosis 
as possible.73 This test-and-treat approach removes all limitations on ART eligibility based on 
CD4+ counts – where patients were previously recommended to start ART when found to have 
less than 250 CD4+ cells/mm3 by a healthcare provider.73 Current treatment goals aim to 
suppress viral loads (typically defined as 50 copies of HIV RNA per milliliter) in all HIV-
infected patients. PLWHIV who maintain durable viral suppression are unable to transmit the 
virus to sexual partners and, as such, gave way to the Undetectable = Untrasmittable (U=U) 
campaign.74,75 
 Achieving U=U can have profound public health significance. A 2017 epidemiological 
study estimated that 1 in 6 GBM in the U.S. will be diagnosed with HIV in their lifetime if 
current incidence trends remain stable.76 Hess et al. found that, although inflated when compared 
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to other subgroups, the lifetime risk estimate for GBM was lower, largely due to current 
combination prevention efforts such as highly-active ART for treatment and PrEP for 
prevention.76  Analyses on the cost-effectiveness of preventing HIV through these methods 
found that interventions aimed at diagnosing and treating HIV were highly cost-effective, 
particularly when aimed at GBM.77   Moreover, Shackman et al.’s analysis found that the 
medical cost saved by avoiding one HIV infection was $229,800 and concluded that the 
economic value of prevention is substantial when compared to the high cost of HIV treatment.78 
Despite the current cost of HIV disease management, ensuring timely linkage to care remains a 
high priority in all prevention efforts given the potential to eradicate forward transmission among 
undetectable PLWHIV.79 Although the quality and efficacy of HIV treatment continues to 
advance, racial\ethnic disparities still persist with regards to retention in HIV care, adherence to 
ART, and viral load suppression.10,22 As such, monitoring the effectiveness of test and treat 
strategies is of utmost importance and necessary for identifying areas of improvement. 
HIV Care Continuum in the United States 
The HIV treatment cascade – often referred to as the HIV care continuum – can be an 
effective tool for monitoring the progress of HIV intervention strategies by outlining and 
modeling the sequential stages of HIV care from diagnosis to viral suppression.80 Advances in 
biomedical strategies to prevent HIV and recent worldwide EHE initiatives, such as the UNAIDS 
90-90-90 goals and U=U, have also led to concerted efforts to monitor HIV testing and PrEP 
uptake.71  
Status Neutral Engagement in Care 
 The New York City Department of Health and Mental Hygiene (DOHMH) proposed the 
status-neutral prevention and treatment cycle, which puts forth a continuum of care irrespective 
of HIV status, for tracking the progress of HIV prevention and care efforts.70,71 This status 
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neutral approach to HIV care is a multidirectional and dynamic model that centers around HIV 
testing and diverges depending on the individual’s status; those who test HIV-negative fall into 
the “HIV Primary Prevention” continuum while those who test positive fall into the traditional 
treatment engagement arm.71 The primary component of the status neutral approach is HIV 
testing, and, as such, concerted efforts have been made to expand access to and use of testing 
services.31,71,81 These efforts have manifested in various ways, such as the incorporation of rapid 
4th generation HIV tests that are able to detect acute HIV in sexual health clinics (e.g., the Alere 
Determine HIV Ab/Ag combo test), and the distribution of free at-home HIV testing kits to 
GBM (e.g., the FDA approved OraQuick in-home rapid HIV test).82,83  
  Point-of-care HIV testing, both in community and medical settings, allows for 
widespread detection of HIV.84  Although we are increasingly able to diagnose HIV at higher 
rates, there is a continued need to understand determinants of seroconversion among GBM and 
to identify the potential barriers to linkage to medical services. Difficulties remain in maximizing 
linkage to care and viral suppression, especially in hard-to-reach sexual minority populations 
who are HIV-positive.9,16,70,71,85 Over one-third of all PLWHIV are not fully engaged in HIV 
primary medical care, and sexual minority populations of color experience starkly worse rates of 
engagement when compared to their white counterparts.9,16,22,70,71,85,86    
Barriers and Facilitators to Engagement in HIV Care for GBM 
  Consistent use of ART is necessary to achieve viral suppression.21,74 Inconsistent use of 
ART may be fueled by individual-level challenges, such as depression, as well as policy-related 
factors such as the high cost of treatment and inadequate insurance status (particularly, whether 
or not an individual is covered by private or government-provided insurance).87 Considering the 
high cost of ART, the barriers to accessing health insurance, and the limited financial resources 
of many PLWHIV, the AIDS Drug Assistance Program (ADAP), a part of Ryan White Part B 
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funding, acts as a last resort provider for ART and other essential HIV-related medications free 
of charge to low-income PLWHIV who qualify for the program.88  Unfortunately, this program 
has been found to be under-utilized by PLWHIV.88 
  Further, engagement in care is heavily dependent on provider-patient relationships. 
Studies have documented the important role providers play in getting patients to come back for 
follow-up visits.48,89-91 Particularly for GBM, providers who are open to discussing matters of 
sexual health and are inclusive have been most successful in retaining patients.87,90,91  In a study 
about PrEP use among GBM in NYC, Jaiswal et al.  found that with less concerns about having 
to talk to providers about their sex life and less concerns about paying for PrEP, the higher the 
odds to be on PrEP.92 Further, using the National Survey on HIV in the Black community 
survey, Ojikutu et al.  found that those with higher knowledge about PrEP and higher use of 
medical services were more willing to initiate and use PrEP.93 Particularly, both studies found 
lower willingness and actual use of PrEP when perceived stigma was high, and trust in the 
healthcare system was low.92,93 These findings are in line with the literature on structural barriers 
specific to sexual minority populations, such as stigma and medical mistrust. Further, 
homelessness, lack of healthcare access, and low availability of PrEP-prescribers have also been 
found to significantly limit PrEP uptake and engagement in HIV care, once diagnosed.26,31,94 
Finally, financial issues, limited insurance coverage, lack of information, and self-perceived low 
risk of HIV exposure were found to be significant barriers to PrEP uptake.95-97 
Rationale for the Dissertation 
  There is an urgent need for continued understanding of unique factors affecting HIV risk 
and engagement in HIV care for GBM. Biological, behavioral and structural factors make the 
dynamics of the epidemic in the U.S. complex.98  Aside from sexuality-related stigma, GBM 
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experience high levels of victimization including intimate partner violence, stress, depression 
and substance use which puts them at a heightened risk for HIV infection.50,87,99 There are little 
recent data on the prevalence of homelessness and incarceration among GBM from across the 
nation. Although we understand that multiple factors may work in tandem to increase HIV risk, 
there are few national studies looking at the additive effect of all these on HIV risk. Further, 
prevention research has largely studied HIV risk through a deficit-based, risk focused approach. 
Research has begun to emerge with a focus on the strengths and resilience of GBM but, overall, 
remains widely understudied. More empirical studies are needed to understand how resilience 
may impact HIV risk. Finally, the U.S. is failing to meet viral suppression targets and there are 
large gaps in the HIV continuum of care for GBM. Over one-third of all PLWHIV are not fully 
engaged in HIV primary medical care, and sexual minority populations of color experience 
starkly worse rates of engagement when compared to their white counterparts.9,16,22,70,71,85,86 
Notably, the largest drop-offs in the prevention engagement continuum occur in provider-
initiated discussions for PrEP eligibility and actual PrEP initiation, pointing towards potential 
disparities and barriers to PrEP initiation.71 As such, there is continued need to understand the 
barriers and facilitators to HIV testing, prompt linkage-to-care and retention in care.  
Specific aims 
  This dissertation uses a multi-method approach to understand factors influencing HIV 
risk and engagement in HIV care among a U.S. national sample of GBM. This study examined 
the individual and contextual factors influencing GBM’s risk and identified potential missed 
prevention and intervention opportunities. The following specific aims were addressed: 
Aim 1: Measure exposure to syndemic conditions, describe the conditions most likely to co-
occur and examine their association to HIV risk.  
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Aim 2: Describe the levels of resilience and identify associations with HIV risk and conduct 
comparisons by race/ethnicity, region, age and other socio-demographic characteristics. 
Aim 3: Describe the barriers and facilitators to engagement in prompt HIV care 3-months after 
the delivery of an HIV-positive result.  
Theoretical Frameworks 
Despite the large body of literature on correlates of HIV risk among GBM, few 
longitudinal studies have been implemented to examine the way these factors are compounded 
for GBM. Aim 1 made use of the Syndemic Theory, which posits that two or more vulnerability 
factors (e.g., depression, anxiety, etc.) work together to diminish health. Syndemic conditions 
can be defined as co-occurring epidemics that have an additive effect on risk, and range from 
physiological (i.e., co-morbities) or psycho-social (i.e., behavioral, social and/or structural) 
factors (Figure 2).100,101 In particular, research has shown a positive association between number 
of syndemic conditions and HIV risk behavior and prevalence but no syndemic studies have 
included homelessness and history of incarceration into its models. Aim 2 was structured through 
a resilience framework in which resilience is conceptualized as a multi-dimensional intrapersonal 
characteristic influencing HIV risk behaviors and protective behaviors.65,102 Resilience appears to 
have an important role in shaping whether or not people recover from adversity and sustain 
healthy growth and functioning.102,103 High levels of well-being protect against elevated levels of 
inflammation, decrease the likelihood of disability and early mortality, and helps people manage 
the negative impact of health changes.57,102,103 Given the continued high numbers of new HIV 
infections among GBM, there is a need to understand the protective role of resilience on HIV to 
develop strength-based prevention interventions that capitalizes on the assets, and resources 
unique to GBM. Finally, Aim 3 was structured through the social ecological model (SEM) to 
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explore the complex interplay of individual, relationship, community, health care system and 
policy factors which influence engagement in HIV care.104 The SEM recognizes that an 
individual’s health may be influenced by individual, interpersonal, social and structural 
factors.104,105  
Organization of the dissertation 
  Following this introduction, the dissertation contains four additional chapters. In chapter 
2, we addressed specific aim 1 in which we used the Syndemic Theory framework to assess the 
prevalence of syndemic conditions and explored its associations with HIV risk. Notably, our 
syndemic model incorporates homelessness and history of incarceration into the assessment of 
cumulative risk for HIV given the heightened HIV vulnerability among GBM experiencing 
homelessness and incarceration. We hypothesized that a syndemic of psychosocial and 
behavioral conditions would be associated with greater HIV risk. Our hypothesis was largely 
supported by the data and provide a compelling case towards the adoption of these new variables 
into future syndemic analyses.  
  In chapter 3, we addressed specific aim 2 using a resilience framework. Using this 
strength-based approach to HIV prevention, we hypothesized that resilience buffered HIV risk. 
Our hypothesis was not fully supported by our analyses, in which we found no statistically 
significant association between resilience and our composite measure of HIV risk. Nonetheless, 
when disaggregating our measure of HIV risk into its behavioral components, we found a 
significant negative association between resilience and condomless receptive anal sex. This led 
us to conclude that resilience may be better conceptualized and measured as a multi-dimensional 




  Chapter 4 addresses specific aim 3 in which we explored linkage, engagement and 
retention in HIV care among participants newly diagnosed with HIV through qualitative in-depth 
interviews. We explored the barriers and facilitators to engagement in care using the 
socioecological framework. Through thematic analyses, we identified four major themes related 
to participants’ engagement in care: 1) Reasons for HIV testing (e.g., HIV self-testing and 
expectation of positivity), 2) Linkage-to-care (e.g., appointment/logistic issues and social support 
as encouragement), 3) Barriers (e.g., financial burden, competing priorities and fear/stigma) and 
facilitators (e.g., financial assistance, patient-provider relationships, auxiliary support services 
and health agency) to engagement in HIV care, and 4) PrEP as a missed prevention opportunity.  
  In chapter 5, we summarize the findings from our specific aims. We also discuss the 
strengths and limitations of our methods and analyses. Finally, we conclude with policy 
implications and directions for future research.  
Data Sources 
  This dissertation uses data collected as part of the Together 5,000 study, a U.S. national, 
internet-based cohort study of men, transgender men, and transgender women who have sex with 
men. The overall goal of the study was to identify modifiable individual and structural factors 
associated with HIV seroconversion and pre-exposure prophylaxis (PrEP) uptake. Enrollment 
began in 2017 using advertisements on geosocial networking phone applications and concluded 
in 2018. This dissertation is a secondary analysis of quantitative data from a cohort of 6,118 
GBM ages 16-49 at high risk for HIV transmission (defined as meeting CDC guidance for PrEP 
use), and qualitative data from 50 GBM diagnosed HIV-positive during their participation in 
Together 5,000. 
  Eligible participants were men, transgender men, and transgender women; aged 16–49 
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years; had at least two male sex partners in the past 3 months; were not currently participating in 
a HIV vaccine or PrEP clinical trial; were not on PrEP at the time of enrollment; lived in the 
United States or its territories; self-reported HIV status as HIV negative or unknown. 
Additionally, eligible participants met at least one of the following criteria: diagnosed (within 
past 12 months) with syphilis, rectal gonorrhea or chlamydia, shared injection drug use in the last 
12 months, self-reported more than one receptive CAS acts with a man in the past 3 months, self-
reported greater than two insertive CAS acts with a man in the past 3 months, took postexposure 
prophylaxis (PEP) in the past 12 months, and/or self-reported methamphetamine use in the past 3 
months. 
Parent Study Procedures 
  Interested participants completed an initial web-based screening survey collecting data on 
sexual behavior, substance use, demographic characteristics, history of PrEP use, and history of 
post-exposure prophylaxis (PEP) use. Eligible participants were asked to complete a secondary 
web-based baseline survey that further assessed psychosocial and network characteristics. Out of 
the 8,777 eligible participants, 6,283 completed the secondary baseline survey and were asked to 
provide a valid mailing address. Participants were then sent an at-home HIV test kit via mail and 
were asked to mail oral fluid samples to the study laboratory for analysis. A full description of 
the Together 5,000 study, recruitment methods and enrollment numbers (Figure 1.4) have been 
previously published.106,107 
  Further, a trained staff member contacted participants to deliver their HIV results over the 
phone. A total of 196 participants tested preliminary HIV-positive at enrollment; results were 
successfully delivered to 132 (67%) of participants. Those who received preliminary HIV-
positive results were provided with a list of clinic referrals for linkage-to-care and support. Three 
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months afterwards, the 132 participants were invited to undergo a qualitative interview about 
their experiences accessing care following results delivery.108 Fifty-four participants agreed to 
participate in the qualitative sub-study. Interviews were conducted by two study staff members 
and the principal investigator. All interviews were conducted over the phone, recorded using a 
call recording earphone device and transcribed verbatim. Transcripts were verified against their 
corresponding audio recording by three study staff members for quality assurance. The Together 
5,000 study protocol was approved by the Institutional Review Board in the Human Research 
Protection Program (HRPP) of the City University of New York (CUNY) Graduate School of 
Public Health and Health Policy. 
Application of Findings 
The findings of this dissertation may be useful in that it expands the application of 
Syndemic Theory by incorporating a unique set of social condition variables, such as 
incarceration and homelessness history, often left out in traditional syndemic analyses. This 
dissertation also explores both deficit- and strength-based approaches to HIV prevention through 
a syndemic framework and a resilience framework. Further, the qualitative data from recently 
diagnosed individual’s experience accessing HIV care provides valuable insights into barriers 
and facilitators to engagement in care across the U.S. As such, this research provides new 
information on the state of the HIV policies and hard to reach populations in the US and 
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Figure 1.1 - CDC Estimated HIV Prevalence and Incidence,1980-2012 
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 Figure 1.4 - HIV Diagnoses among GBM, 2006-2017 
 
Figure 1.5 - HIV Diagnoses among GBM, 2006-2017 
*Line graph created using data from the CDC HIV Surveillance Reports Vols. 17-19, 29. 
 
Figure 1.3 - HIV Diagnoses among GBM, 2006-2017*Line graph created using data from the 






Figure 1.7 - HIV Incidence in NYC, GBM, 2012-2016 
*Obtained from the CUNY Institute for Implementation Science in Population Health’s End 
the Epidemic Dashboard. 
 
Figure 1.6 - HIV Incidence in NYC, GBM, 2012-2016*Obtained from the CUNY Institute for 
Implementation Science in Population Health’s End the Epidemic Dashboard. 
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Figure 1.4 - Together 5,000 Enrollment Flowchart 
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CHAPTER 2: THE ASSOCIATION BETWEEN SYNDEMIC CONDITIONS AND HIV 
RISK IN AN U.S. NATIONAL COHORT OF GAY, BISEXUAL AND OTHER MEN 




Background: Gay, bisexual and other men who have sex with men (GBM) continue to be at 
disproportionate risk for HIV. Nonetheless, few studies have looked at the role of psycho-social 
syndemics on HIV risk in large national samples of MSM.  
 
Methods: 6,118 MSM completed a cross-sectional survey on socio-demographics, HIV risk 
behaviors, mental health and substance use as part of the Together 5,000 study, an U.S. national 
cohort of men, transgender women and transgender men who have sex with men. We evaluated 
the prevalence of syndemic conditions and explored its associations with HIV risk.  
  
Results: Participants’ mean age was 30.6 years (SD=7.9); 52.2% identified as white, 24.6% as 
Hispanic/Latino and 11% as Black. Half of participants (50.4%) reported some intimate partner 
violence (IPV), while one-quarter reported symptoms of anxiety (30.6%), depression (28.8%), and 
experiences of childhood sexual abuse (CSA, 24.3%). Moreover, 21.2 % and 11.9% reported 
hazard alcohol and polydrug use, respectively. One-fifth (20.3%) reported at least two co-
occurring syndemics. In multiple linear regressions, IPV (β = 1.07, p < 0.001), childhood sexual 
abuse (β = 0.54, p < 0.05), polydrug use (β = 5.62, p < 0.001), incarceration history (β = 1.91, p < 
0.001) and homelessness (β = 2.31, p < 0.001) were positively associated with HIV risk. Further, 
increasing cumulative syndemic conditions were associated with higher HIV risk (F(14, 6103) = 
62.7, p < 0.001). For instance, HIV risk increased with one (β = 1.06, p < 0.001), two (β = 1.54, p 
< 0.001), three (β = 2.88, p < 0.001), four (β = 4.16, p < 0.001) and more than four (β = 7.04, p < 
0.001) co-occurring syndemics. 
 
Conclusions: We found further evidence of psychosocial and substance use problems among 
MSM our cohort. Increasing syndemic burden was associated with greater HIV risk. Our findings 
highlight the need for interventions that address psychosocial health outcomes, within the context 




  HIV continues to be a pervasive public health issue in the United States.1,2 Although new 
HIV diagnoses have been declining over the last decade, the number of incident cases of HIV 
among Gay, Bisexual and other men who have sex with me (GBM) has remained relatively 
stable.2-8 Notably, the proportion of HIV cases among GBM has been increasing slightly since 
2011.2-8  In 2017, there were 38,739 new HIV diagnoses in the U.S.; GBM accounted for over 
two-thirds (27,000, 70%) of all new HIV diagnoses.2,3,5,9 Particularly, young GBM (under the 
age of 35 years) accounted for 64% of all new HIV diagnoses among all GBM in 2017.3-6 The 
rate of diagnoses for those aged 25 to 34 increased by 26% from 2010 to 2016.3-6 At this rate, 
one in six GBM will acquire HIV in their lifetime, including one in two Black GBM and one in 
for Latino GBM, thus warranting continued and concerted efforts for prevention and intervention 
in sexual minority populations.2,3,6 
  GBM experience high levels of adverse psychosocial conditions such as depression,10,11 
problematic alcohol consumption and substance use,12,13 exposure to violence (e.g., intimate 
partner violence)14,15 and homelessness16-18 that puts them at heightened risk for HIV infection.19-
21 In fact, analyzing HIV risk through a syndemic framework can provide a nuanced 
understanding of how behavioral and psychosocial factors can compound HIV vulnerability.13,22-
25 The Substance Abuse, Violence and HIV/AIDS (SAVA) model of syndemics describes how the 
confluence of substance use, violence, and sexual risk behaviors interact to exacerbate HIV 
burden among vulnerable populations.14,22,23,26 Other models expanded on the SAVA model to 
incorporate psychosocial variables (e.g., depression, childhood sexual abuse, sexual 
compulsivity, etc.) that have provided a more complex view of the unique risk factors affecting 
GBM in the U.S.23,26 Past research has demonstrated the additive risk these psychosocial 
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conditions can have on an individual’s health. 13,19,24,26  One study of 1,033 HIV-negative GBM 
from across the U.S. found that at least 62% of men reported at least one syndemic condition and 
found that HIV transmission risk behaviors were highest among those reporting three or more 
syndemic conditions.23,26 Another study of 464 Latino GBM in Philadelphia, PA, found 
participants with two or more factors reported more male partners and more CAS with casual 
male partners than those with none.27 Further, Martinez et al.  led a study of 176 Hispanic men 
and transgender women in New York City and found that those who reported three or four 
syndemic factors were significantly more likely to report heavy drinking, and found an 
association between heavy binge drinking, and having multiple sexual partners.13 Another study 
of 100 gay male couples living in the U.S. found that syndemics contribute to HIV transmission 
risk between main sexual partners.28 Notably, these studies highlight the need for extended 
research with larger geographically diverse samples that incorporate other social condition 
variables, such as homelessness and incarceration, that have also been found to be prevalent and 
important for understanding risk among GBM but often left out of the syndemic analyses.8,14,16-
19,23,24,26,29  
  Research indicates that sexual minority adults make up a significant proportion of the 
homeless adult populations in the United States; about 20 to 40% of the homeless population 
despite being about 5% of the general population.30-33 Young adults are 8 times more likely to 
experience homelessness.30,32 In fact, the Ali Forney Center reports that 42% of the homeless 
youth in New York City are sexual minorities; 49% male and 90% persons of color.34 Further, 
those experiencing homelessness are at risk of a plethora of risk behaviors and negative health 
outcomes, such as engaging in high-risk sexual behaviors and commercial sex work, contracting 
HIV and other STIs, and at higher risk of victimization.30-32,34 Further, incarceration is a concern 
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among GBM. In a 2017 study, Meyer et al.  found that about 9% of men in prison and 6% of 
men in jail self-identify as gay or bisexual; they estimate that the incarceration rate of sexual 
minority adults was 1882 per 100 000, more than 3 times that of the US adult population.35 
Similarly, those with a history of incarceration have been found to have a higher risk for HIV.35-
39 Given the heightened HIV vulnerability among those experiencing lifetime homelessness and 
incarceration, these variables should be explored in syndemic analyses. 
  The present study extends the recent work on syndemics and HIV risk by 
exploring eight syndemic conditions (intimate partner violence, depression, anxiety, childhood 
sexual abuse, polydrug use, hazard alcohol use, incarceration history and homelessness) among a 
national sample of GBM in the U.S. Using a syndemic framework, we hypothesized that a 
syndemic of psychosocial and behavioral conditions would be associated with greater HIV risk.  
 
METHODS 
 Cohort recruitment, enrollment, and surveys 
 This study uses data collected as part of the Together 5000 study, a U.S. national, 
internet-based cohort study of men, transgender men, and transgender women who have sex with 
men. The overall goal of the study is to identify modifiable individual and structural factors 
associated with HIV seroconversion and PrEP uptake. Enrollment began October 2017 using ads 
on men-for-men geosocial networking phone applications and concluded in June 2018. 
Participants were eligible if they identified as cisgender men, transgender men, or transgender 
women; were between the ages of 16 and 49 years; had at least 2 male sexual partners in the last 
3 months; were not currently participating in a HIV vaccine or PrEP clinical trial; were not on 
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PrEP at the time of enrollment; lived in the US or its territories; self-reported HIV status as HIV-
negative or unknown; and met at least one of the following additional criteria: diagnosed with 
syphilis, or rectal gonorrhea/chlamydia in the last 12 months, shared injection drug use needles 
in the past 12 months, self-reported more than one receptive CAS acts with a man in the past 3 
months, self-reported greater than two insertive CAS acts with a man in the past 3 months, took 
post-exposure prophylaxis (PEP) in the past 12 months, and/or self-reported methamphetamine 
use in the past 3 months. Notably, the recruitment strategies were targeted to reach GBM, but our 
enrollment criteria did not exclude transgender men and transgender women who otherwise met 
study criteria. Nonetheless, transgender individuals were excluded in the present analysis 
because they are faced with a complex interplay of multi-level psychosocial stressors that may 
differentially impact HIV compared to GBM.40 Participants were directed to a secured informed 
consent and enrollment survey webpage that presented questions about demographic 
characteristics, sexual behavior, and substance use. Eligible participants who consented and 
completed the enrollment survey (Appendix A) were later sent a link (email and text) to 
complete a secondary survey (Appendix B) that collected additional behavioral data. Participants 
completing this secondary survey received a $15 gift card by email.  
HIV testing 
Participants who completed the second survey were subsequently mailed an OraSure 
HIV-1 oral specimen collection device to assess current HIV status. Using a self-addressed and 
stamped envelope, participants mailed oral fluid samples to the study lab for analysis. 
Participants who returned a sample to the lab received another $15 gift card by e-mail. A full 




  Variables of interest for the current study included demographic characteristics, sexual 
heath factors related to HIV risk and HIV testing, and HIV vulnerability factors (syndemics): 
Polydrug use, hazard alcohol use, Depression, Anxiety, Childhood sexual abuse, Intimate partner 
violence, Incarceration history and housing instability. Demographic characteristics measured in 
the enrollment survey included age, race/ethnicity, sexual identity (e.g., gay, bisexual), 
employment status, highest level of education, annual income, health insurance status, and 
having performed sex work in the past 3 months. Sexual health variables included perceived HIV 
status at enrollment (negative vs. unknown), HIV testing history, experience with PrEP and PEP, 
as well as the number of times participants had insertive and/or receptive CAS in the past 3 
months. 
  HIV risk was measured using the MSM Risk Index43,44, a tool for systematically 
determining risk for HIV acquisition with a sensitivity of 84% and a specificity of 45% for 
predicting incident HIV infection in the next six months.43,44 The MSM-Risk index is a validated 
screening tool for calculating HIV risk among GBM that incorporates age, number of male 
partners, number of HIV-positive male partners, frequency of condomless receptive anal sex, 
frequency of condomless insertive anal sex with HIV-positive partners and use of amyl nitrate 
(“poppers”) and methamphetamines.43,44 Risk scores ranged from 0 to 45; higher scores point 
towards higher HIV risk.43,44  
  We identified the following as HIV vulnerability factors based on an expanded Syndemic 
framework. Polydrug use was determined based participants reported use of cocaine, crack, 
crystal methamphetamine, marijuana, ecstasy, gamma-hydroxybutyrate (GHB), ketamine, 
heroin, and poppers in the last 90 days. Participants reporting use of three or more will be coded 
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as having engaged in polydrug use. Hazard alcohol use was assessed using the alcohol use 
disorders identification test (AUDIT), a 10-item questionnaire to screen for hazardous alcohol 
use. The scores can range from 0 to 40, with a score between 8 and 14 depicting hazard alcohol 
use (1, yes or 0, no). An indication for depression was measured using the Patient Health 
Questionnaire (PHQ-2), which screens for depression with a sensitivity of 86% and specificity of 
78%.45 PHQ-2 score ranges from 0-6, with a score of 3  of greater as the optimal cut off point to 
screen for major depressive disorder.45 An indication for anxiety was measured using the 
General Anxiety Disorder scale (GAD-2), which screens for anxiety with a sensitivity of 86% 
and specificity of 83%.46 GAD-2 score ranges from 0-6, with a score of 3  of greater as the 
optimal cut off point to screen for general anxiety disorder.46 Childhood sexual abuse was 
determined by asking participants if they had experienced sexual activity, into which they felt 
forced or scared by someone who was older than them, and whether they were aged 16 or 
younger at the time (0, no; 1, yes).47 Intimate partner violence was assessed through an 
adaptation of the Revised Conflict Tactics Scale, a 12-item questionnaire that measured 
unwanted physical or emotional abuse.48  Participants who responded yes to any of the items 
were coded as a yes on a dichotomous variable indicating intimate partner violence (0, no; 1, 
yes). Incarceration history was determined by asking participants whether or not they had ever 
been incarcerated. Answers will be coded as a dichotomous variable (0, no; 1, yes). Finally, 
housing instability was determined by asking participants if they had unstably housed (e.g., 
couch surfing, homeless) in the last five years (0, no; 1, yes).  
Analysis Plan 
  Our objective was to: 1) assess the prevalence of syndemic conditions in a large 
geographically diverse sample of GBM; 2) to explore the associations between individual and 
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cumulative syndemics, and HIV risk. Descriptive statistics were used to describe the sample (n = 
6,118). The median number of syndemic conditions was compared across demographic 
characteristics using a median test. Frequencies were used to determine the prevalence of 
individual and cumulative syndemic conditions reported by participants. Bivariate associations 
between the presence of each syndemic condition and HIV risk were calculated as odds ratios. 
Further, we assessed the association of each individual syndemic factor on HIV risk using 
multiple linear regression. Finally, a multiple linear regression was used to test the additive effect 
of the syndemic factors (presence of multiple factors) and HIV risk. Linear regressions were 
adjusted for age, race, sexuality, employment status, current health insurance status, and income. 
Statistical significance was set at the 0.05 level. All analyses were conducted using SPSS 26. 
These procedures were reviewed and approved by the Institutional Review Board at The City 
University of New York’s Graduate School of Public Health and Health Policy. 
 
RESULTS 
  Descriptive statistics for demographic characteristics and comparisons of the number of 
participants within each demographic characteristic reporting more than the median number of 
syndemic conditions are presented in Table 2.1. Participants (n = 6,118) had a mean age of 30.6 
years (SD = 7.9). The majority identified as Gay, Queer or Homosexual (85%) and did not have 
a main sexual partner (73.3%). Participants identified as white (52.2%), Hispanic/Latino 
(24.6%), black (11%), multiracial (8.7%) and Asian/Pacific Islander (3.5%). Nearly two-thirds 
(62.6%) reported being fully employed, 45% reported having some college education, 41.7% 
reported an annual income between $20,000 and $49,999, and 48.4% lived in southern states of 
the U.S. A quarter (27.4%) reported that they did not have/were unsure if they had health 
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insurance and 14.6% reported engaging in transactional sex in the past 3 months. Finally, over 
half self-reported as HIV-negative (58.2%), and one-quarter (26.3%) reported that their last HIV 
test was more than a year ago. Using median analyses, a higher proportion of syndemics was 
found among participants who identified as Latino and multiracial, reported lower levels of 
education and income, were unsure of their HIV status and had most recently tested more than a 
year ago, and who had engaged in sex work in the last 12 months. 
  The prevalence of syndemic conditions are presented in Table 2.2. Half of participants 
(50.4%) reported intimate partner violence (IPV), while roughly one-quarter reported symptoms 
of anxiety (30.6%), depression (28.8%), and childhood sexual abuse (CSA, 24.3%); one-fifth 
(20.3%) reported unstable housing within the last 5 years, and 14.5% reported having been 
incarcerated at least once in their lives. Moreover, 21.2 % and 11.9% reported hazard alcohol 
and polydrug use, respectively. One-quarter (24.7%) of participants reported one syndemic 
condition, 20.3% reported two co-occurring syndemics, 15.8% reported three, 10.3% reported 
four, and 8.8% reported more than four co-occurring syndemics. 
  The bivariate associations between syndemic conditions, expressed as odds ratios (ORs), 
are presented in Table 2.3. The majority of the syndemic conditions were associated with each 
other and with HIV risk. Nonetheless, there were no statistically significant associations 
between: polydrug use and depression, and polydrug use and CSA. There were no statistically 
significant association between hazard alcohol use, and depression, anxiety and CSA. Further, no 
association was found between incarceration and anxiety, homelessness and anxiety, and 
homelessness and alcohol use. 
  Table 2.4 displays the unadjusted and adjusted linear regression models of HIV risk and 
individual syndemic conditions (model 1), as well as cumulative syndemics (model 2).  In the 
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unadjusted multiple linear regression for Model 1 (F(8, 6109) = 115.99, p < 0.001), IPV (β = 
1.20, p < 0.001), depression (β = 0.55, p < 0.05), polydrug use (β = 5.78, p < 0.001), 
incarceration history (β = 1.36, p < 0.001) and homelessness (β = 2.79, p < 0.001) were 
positively associated with HIV risk. After adjusting for control variables, the relationship 
between depression and HIV risk was not statistically significant; conversely, the relationship 
between CSA and HIV risk became statistically significant (β = 0.53, p < 0.05). Finally, in the 
adjusted multiple linear regressions for Model 2, increasing cumulative syndemic conditions 
were associated with higher HIV risk (F(14, 6103) = 66.32, p < 0.001). For instance, HIV risk 
increased with one (β = 1.23, p < 0.001), two (β = 1.46, p < 0.001), three (β = 3.06, p < 0.001), 
four (β = 4.40, p < 0.001) and more than four (β = 7.40, p < 0.001) co-occurring syndemics. 
 
DISCUSSION 
  We examined the association between eight syndemic conditions (IPV, depression, 
anxiety, CSA, polydrug use, hazard alcohol use, incarceration history and homelessness) and 
HIV risk in a national sample of HIV-negative cis-gender gay and bisexual men. We found 
additional evidence that these social conditions intersect to exacerbate HIV risk. This study also 
underlines the importance of including syndemics beyond substance use and violence in 
syndemic research. We demonstrate that environmental and behavioral factors such as 
homelessness, incarceration are prevalent among GBM in the U.S. and contribute to HIV 
acquisition. Consistent with the literature and current trends in the HIV epidemic, syndemics 
were particularly common among populations most at risk for HIV, including those identifying 
as Latino/Multiracial, with lower income and educational attainment, who engage in commercial 
sex work, who were unsure of their HIV status and those who had not tested for HIV in the last 
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year. Overall, our analyses provided evidence that increasing syndemic burden was associated 
with greater HIV risk.  
  Our study provides valuable insights on the prevalence of homelessness and incarceration 
among sexual minority men. Past studies have estimated the rates of recent homelessness and 
history of incarceration among sexual minority individuals across the U.S. but there is a dearth of 
recent data from geographically diverse samples of GBM. Although studies support the 
association between incarceration and HIV risk,37,39,49 a 2010 meta-analysis by Gough et al.  does 
not support this relationship.50 Our data illustrate that, not only are they both prevalent among 
GBM, but they are significantly associated to increasing HIV Risk. In fact, public health 
practitioners recognize housing instability and incarceration as important social determinants of 
health and as catalysts for worsening health outcomes.51-53 Further, those with a history of 
incarceration are much more likely to become homeless.54,55 As such, there is compelling  
evidence to justify their adoption in future syndemic models.  
  Given the shift to a biomedical paradigm of prevention, understanding the complexities 
of men’s lives is pivotal. This warrants a more comprehensive investigation of the unique risk 
factors in this population, particularly those that may impact uptake and adoption of preventive 
HIV health behaviors, such as pre-exposure prophylaxis (PrEP). For instance, larger structural 
factors like societal racial discrimination, anti-immigration laws, lack of health insurance 
coverage and unemployment can significantly impact adherence to biomedical tools and use of 
testing services.56,57 Future research should explore these social and structural determinants 
within the context of HIV prevention.  
  There is a need for targeted interventions for those at the highest risk, particularly racial 
and ethnic minorities and those from impoverished communities to increase HIV testing 
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frequency and facilitate better engagement in care. Further, as seen in our study findings, HIV 
prevention is a multi-faceted process. As such, there is a need for a more holistic approach to 
prevention, wherein HIV prevention is conceptualized as more than just HIV testing and PrEP 
initiation. Literature on adherence to antiretrovirals and viral suppression has found that housing 
assistance, and mental health and substance use counselling is pivotal towards maximizing health 
outcomes that, if not addressed in tandem, may reduce the effectiveness of U=U goals.18,57-60 As 
such, there are grounds for adopting similar models in the HIV-negative continuum of care. For 
instance, community-based case management and patient navigators could be successful at 
helping patients manage their financial, social, and provider-related barriers to HIV 
prevention.61,62 
Limitations 
  Our findings should be interpreted through careful consideration of its limitations. First, 
the cross-sectional design of this study prevents making any conclusive causal claims about the 
temporality and directionality of the relationships we observed. This study was not designed to 
prove causation, only to assess associations, and therefore causal inferences should be interpreted 
with caution.63 Although this fully online study allowed for increased geographical reach, it also 
increased the potential for fraudulent participants.61,62 This study relied exclusively on data from 
self-reported surveys and, while measures to increase the validity of the data were put into place, 
social desirability and recall bias may have affected the study findings.64 Further, our surveys 
were only delivered in English, as such, our findings may not reflect the experiences of GBM 
who speak other languages. Additionally, the study population was recruited via sexual 
networking apps and represented a sample of those at highest risk for HIV, who are not on PrEP 
at enrollment. Given the non-probability sampling, we are unable to generalize these results to 
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other GBM. Finally, our findings are limited to a sample of HIV-negative cis-gender men and we 
cannot rule out that there may be unique syndemics impacting other gender non-conforming 
participants and those who are HIV-negative.  
Conclusion 
To our knowledge, this is the first study to assess syndemics among a large, geographically 
diverse group of GBM in the U.S. This is particularly important given the relative invisibility of 
data from GBM outside of larger urban centers and a rapidly evolving epidemic.65-69 Our study 
underlines the socioeconomic vulnerabilities impacting GBM across the U.S., particularly among 
racial/ethnic minorities. Our syndemic models showed that the presence of multiple co-ocurring 
factors, including psychosocial variables such as homelessness and incarceration, were 
significantly impacting HIV risk. Future studies should further explore the impact of additional 
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Table 2.1: Demographic characteristics of the Together 5,000 study, and number of participants above the median 
number of syndemic conditions, n = 6,118 
Characteristic Frequency % Freq above median % Median Test χ² 
Race/Ethnicity           
  White 3191 52.2 1028 32.2 49.03* 
  Black 674 11.0 206 30.6   
  Latino 1505 24.6 490 32.6   
  Asian/Pacific Islander 217 3.5 30 13.8   
  All Other Multi 531 8.7 212 39.9   
Sexual Orientation           
  Gay, Queer, Homosexual 5198 85.0 1647 31.7 14.9* 
  Bisexual 864 14.1 288 33.3   
  Other 56 0.9 31 55.4   
Education           
  < High school diploma 139 2.3 68 48.9 164.6* 
  High school diploma or GED 869 14.2 350 40.3   
  Some college or technical school training 2752 45.0 1010 36.7   
  College graduate + 2358 38.5 538 22.8   
Employment Status           
  Full-time (40 hours per week) 3831 62.6 1038 27.1 163.8* 
  Part-time (less than 40 hours per week) 785 12.8 313 39.9   
  Working- or full-time student 492 8.0 145 29.5   
  Unemployed/Other 1010 16.5 470 46.5   
Annual Income           
  Less than $20,000 2014 32.9 842 41.8 207.3* 
  $20,000-$49,999 2554 41.7 828 32.4   
  $50,000+ 1550 25.3 296 19.1   
Has a main partner           
  Yes 1634 26.7 476 29.1 9.03* 
  No 4484 73.3 1490 33.2   
Health Insurance           
  Yes 4443 72.6 1236 27.8 137.9* 
  No/do not know 1675 27.4 730 43.6   
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Engaged in sex work (past 12 months)           
  Yes 895 14.6 355 39.7 222.7* 
  No 5223 85.4 1476 28.3   
Self-reported HIV Status           
  HIV-negative 3559 58.2 969 27.2 93.9* 
  I don't know; I am unsure 2559 41.8 997 39.0   
Have you ever been tested for HIV?           
  In the past 12 months 3746 61.2 1130 30.2 18.2* 
  More than a year ago 1612 26.3 579 35.9   
  Never 760 12.4 257 33.8   
Region           
  Northeast 911 14.9 243 26.7 19.2* 
  South 2950 48.4 993 33.7   
  Midwest 887 14.5 272 30.7   
  West 1323 21.7 446 33.7   
  Pacific, US Territories, Others 47 0.8 6 12.8   
    M SD       
Age 30.6 7.9       
*p < 0.05 
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Table 2.2. Syndemic prevalence in the Together 5,000 cohort 
 Frequency (%) 
IPV 3081 50.4 
Depression 1763 28.8 
Anxiety 1873 30.6 
CSA 1485 24.3 
Polydrug use 731 11.9 
Hazard Alcohol Use 1300 21.2 
Incarceration History 886 14.5 
Homelessness 1243 20.3 
Cumulative Syndemics Frequency (%) 
One Syndemic 1512 24.7 
Two Syndemics 1241 20.3 
Three Syndemics 967 15.8 
Four Syndemics 630 10.3 
More than Four 539 8.8 
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Table 2.3. Bivariate associations among syndemic conditions and HIV risk 
  




  OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
IPV 2.06* (1.8, 2.3) 1.53* (1.3, 1.8) 1.97* (1.7, 2.3) 1.712* (1.4, 2.1) 1.2* (1.04, 1.34) 1.88* (1.6, 2.20) 1.96* (1.7, 2.3) 
Depression - 18.01* (15.7, 20.7) 1.36* (1.2, 1.6) 1.1 (0.9, 1.4) 0.87 (0.73, 1.03) 1.28* (1.05, 1.56) 1.7* (1.4, 2.03) 
Anxiety  - 1.49 *(1.3, 1.7) 1.4* (1.1, 1.7) 1.14 (0.97, 1.35) 1.03 (0.84, 1.25) 1.16 (0.97, 1.4) 
CSA   - 0.99 (0.83, 1.2) 1.05 (0.90, 1.21) 1.65* (1.4, 1.9) 1.61* (1.4, 1.9) 
Polydrug use    - 
1.55* (1.29, 
1.86) 
2.33* (1.92, 2.82) 1.64* (1.4, 1.98) 
Hazard Alcohol 
Use 
    - 0.78* (0.64, 0.94) 0.85 (0.72, 1.01) 
Incarceration       - 2.91* (2.5, 3.4) 
Homelessness       - 




Table 2.4 Linear Regressions of HIV Risk by Individual and Cumulative Syndemics 
Model 1: Individual Syndemics b SE P-Val F(df) Adj-R2 Adjusted b* SE P-Val F(df) Adj-R2 
IPV 1.21 0.20 0.00 116.3 (8, 6109) 0.131 1.068 0.194 0.00 77.5 (17, 6100) 0.175 
Depression 0.55 0.26 0.04 - - 0.248 0.258 0.34 - - 
Anxiety 0.49 0.26 0.06 - - 0.346 0.252 0.17 - - 
CSA 0.36 0.23 0.11 - - 0.538 0.222 0.02 - - 
Polydrug use 5.81 0.30 0.00 - - 5.622 0.295 0.00 - - 
Hazard Alcohol Use -0.32 0.23 0.17 - - -0.512 0.227 0.02 - - 
Incarceration History 1.35 0.28 0.00 - - 1.908 0.28 0.00 - - 
Homelessness 2.78 0.25 0.00 - - 2.307 0.25 0.00 - - 
Model 2: Cumulative Syndemics^  b SE P-Val F(df) Adj- R2 Adjusted b* SE P-Val F(df) Adj- R2 
One 0.18 0.18 0.50 88.6 (5, 6112) 0.067 1.06 0.29 0.00 62.70 (14, 6103) 0.124 
Two 0.64 0.27 0.02 - - 1.54 0.30 0.00 - - 
Three 1.61 0.28 0.00 - - 2.88 0.32 0.00 - - 
Four 3.24 0.35 0.00 - - 4.16 0.37 0.00 - - 
More than Four 6.81 0.38 0.00 - - 7.04 0.39 0.00 - - 
^Reference group: 0 factors 




CHAPTER 3: EXPLORATION OF THE ASSOCIATION BETWEEN RESILIENCE 
AND HIV RISK BEHAVIORS AMONG GAY, BISEXUAL AND OTHER MEN WHO 
HAVE SEX WITH MEN (GBM) ACROSS THE UNITED STATES. 
 
ABSTRACT 
Background: Gay, bisexual and other men who have sex with men (GBM) continue to be at 
disproportionate risk for HIV, predominantly those from racial/ethnic minority populations. 
Further, minority GBM experience higher rates of mental health issues and substance use that 
put them at higher risk for HIV. Resilience is an intrapersonal factor among GBM that has 
been hypothesized to buffer syndemic factors and HIV risk yet remains widely understudied 
among sexually active GBM. As such, we examined patterns of resilience among a U.S. 
national cohort of GBM.  
 
Methods: 6,118 cisgender men completed a cross-sectional survey on demographics, HIV 
risk behaviors, HIV and STI testing history, and mental health as part of the Together 5,000 
study, an U.S. national, internet-based cohort of men, transgender women and transwomen 
who have sex with men. We explored racial and ethnic differences in resilience (using the 
Connor-Davidson Resiliency Scale CD-Risc-10), and its associations with HIV risk 
behaviors.  
 
Results: Mean age of participants was 30.6 years (SD = 7.9); 52.2% identified as White, 
24.6% as Hispanic/Latino, 11.1% as Black and 8.7% as Asian/Pacific Islander. Over one-
third of participants (38.5%) had at least a college degree, and over half (62.6%) worked full-
time. Over half self-reported as HIV-negative (58.2%), one-quarter (26.3%) reported that 
their last HIV test was more than a year ago. Mean CD-Risc-10 score was 28.97 (SD = 6.07, 
Median = 29, Inter-quartile range = 25, 33). There was a significantly higher mean resilience 
among those identifying as black, with higher education, having full-time employment, 
having an annual income of $50,000, having health insurance, being HIV-negative, and 
having tested in the last year. Moreover, there was a significantly lower mean resilience 
among those engaging in transactional sex in the last 12 months and among those having 
been diagnosed with an STD in the last 12 months. We found no statistically significant 
association between resilience and our composite measure of HIV risk (β = 0.02 [95% CI: 
0.02, 0.06]) in adjusted multiple linear regression analyses. Nonetheless, we found a 
significant association between higher resilience and lower condomless receptive anal sex 
acts in the last 3 months (β = 0.10 [95% CI: -0.17, -0.04], p < 0.001).  
 
Discussion: Our study may have been limited in its ability to fully measure resilience and 
could have accounted for our non-significant findings. The CD-Risc only measures 
adaptability and coping, and although this is an acceptable construct to measure, resilience 
may be better conceptualized as a multi-dimensional factor. It may also be more appropriate 
to measure the association between resilience and HIV risk by focusing on specific sexual 
behaviors rather than a composite measure of sexual risk. Our findings highlight gaps and the 
need to promote health-enhancing positive factors in HIV intervention work. 
 52 
INTRODUCTION 
  HIV continues to be a pervasive public health issue in the United States.1,2 Although 
new HIV diagnoses have been declining over the last decade, the number of incident cases of 
HIV among Gay, Bisexual and other men who have sex with me (GBM) has remained 
relatively stable.2-8 Notably, the proportion of HIV cases among GBM has been increasing 
slightly since 2011.2-8  In 2017, there were 38,739 new HIV diagnoses in the U.S.; GBM 
accounted for over two-thirds (27,000, 70%) of all new HIV diagnoses.2,3,5,9 Young GBM 
(under the age of 35 years) accounted for 64% of all new HIV diagnoses among all GBM in 
2017.3-6 The rate of diagnoses for those aged 25 to 34 increased by 26% from 2010 to 2016.3-
6 At this rate, one in six GBM will acquire HIV in their lifetime, including one in two Black 
GBM and one in four Latino GBM, thus warranting continued and concerted efforts for 
prevention and intervention in sexual minority populations.2,3,6 A concerted response to the 
HIV epidemic requires contextualized and multi-level research and prevention for GBM. As 
such, there is dire need to fully understand the contexts that shape men’s HIV risk. 
Intrapersonal traits, such as resilience, may mitigate HIV among GBM, particularly those 
from racial minority groups.10  
  Resilience is a multi-dimensional intrapersonal characteristic that positively 
influences self-efficacy and adaptive coping and has been thought to contribute to better 
health and decreased HIV risk through behavioral, psychological and physiological 
mechanisms.11,12 There is a growing body of literature that documents cross-sectional 
associations among greater levels of resilience, protective sexual behaviors (e.g., consistent 
condom use), and a lower HIV prevalence.12-15 A study of Black GBM in Texas found that 
social support, a resilience psychosocial factor, was positively associated with more frequent 
HIV testing and higher rates of consistent condom use during anal sex.16 Another study of 
Black GBM in southern states found that individuals with higher resilience scores had a 
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lower prevalence of condomless sex.17 Another study saw a negative correlation between 
higher resilience and heavy substance use and mental health issues, and prevalent HIV 
infection.18  
A resilience framework posits that GBM possess resilience that enables them to 
process experiences with homophobia and heteronormativity and, as such, thrive through the 
adversity brought on by HIV/AIDS.19,20 This framework implies a departure from deficit-
based research and could denote an opportunity to build on strength-based approaches to the 
public health response to HIV/AIDS. Further, it focuses on protective factors that originate at 
the individual level, such as coping, and translates to factual resources at the community 
level, such as social support. Herrick et al.  describe how social support and high community 
involvement are associated with decreased risk behaviors and conclude that harnessing the 
strengths and resilience of GBM may enhance HIV prevention programs and, thus, reverse 
trends in infection.19-21 Nevertheless, the majority of the published literature on resilience 
remains largely theoretical.  
Resilience also remains widely understudied in the HIV literature. Only one published 
study has specifically looked at the direct relationship between resilience and HIV risk 
behaviors.17 However, this study focused solely on Black GBM from Atlanta, Georgia and 
Jackson, Mississippi.17 To our knowledge, there have been no published national studies 
looking at the relationship between resilience and HIV risk behaviors in large geographically 
diverse samples of sexually active GBM. Given this, the present study fills this gap in 
knowledge by determining the geographic, racial and socio-demographic differences in 
resilience among a U.S. national sample of GBM in the U.S. Further, this study explores the 
association between HIV risk and resilience; hypothesizing that resilience is associated with 
lower HIV risk. 
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METHODS 
 Cohort recruitment, enrollment, and surveys 
  This study uses data collected as part of the Together 5000 study, a U.S. national, 
internet-based cohort study of men, transgender men, and transgender women who have sex 
with men. The overall goal of the study is to identify modifiable individual and structural 
factors associated with HIV seroconversion and PrEP uptake. Enrollment began October 
2017 using ads on men-for-men geosocial networking phone applications and concluded in 
June 2018. Participants were eligible if they identified as men, transgender men, or 
transgender women; were between the ages of 16 and 49; had at least 2 male sexual partners 
in the last 3 months; were not currently participating in a HIV vaccine or PrEP clinical trial; 
were not on PrEP at the time of enrollment; lived in the US or its territories; self-reported 
HIV status as HIV-negative or unknown; and met at least one of the following additional 
criteria: diagnosed with syphilis, or rectal gonorrhea/chlamydia in the last 12 months, shared 
injection drug use needles in the past 12 months, self-reported more than one receptive CAS 
acts with a man in the past 3 months, self-reported greater than two insertive CAS acts with a 
man in the past 3 months, took post-exposure prophylaxis (PEP) in the past 12 months, 
and/or self-reported methamphetamine use in the past 3 months. Notably, the recruitment 
strategies were targeted to reach GBM, but our enrollment criteria did not exclude 
transgender men and transgender women who otherwise met study criteria. Nonetheless, 
transgender men and women were excluded in the present analysis because they are faced 
with unique psychosocial stressors and buffers that may differentiate them from GBM.22  
  Participants were directed to a secured informed consent and enrollment survey 
webpage that presented questions about demographic characteristics, sexual behavior, and 
substance use. Eligible participants who consented and completed the enrollment survey 
(Appendix A) were later sent a link (email and text) to complete a secondary survey 
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(Appendix B) that collected additional behavioral data. Participants completing this 
secondary survey received a $15 gift card by email. Participants who completed the second 
were subsequently mailed an OraSure HIV-1 oral specimen collection device. Using a self-
addressed and stamped envelope, participants mailed oral fluid samples to the study lab for 
analysis. Participants who returned a sample to the lab received another $15 gift card by e-
mail. A full description of the recruitment methods and of the Together 5,000 cohort have 
been previously published.23,24 
Study measures 
  The outcome of interest in this study is HIV risk; measured using the MSM Risk 
Index25,26, a tool for systematically determining risk for HIV acquisition with a sensitivity of 
84% and a specificity of 45% for predicting incident HIV infection in the next six 
months.25,26 The MSM-Risk index is a validated screening tool for calculating HIV risk 
among MSM that incorporates age, number of male partners, number of HIV-positive male 
partners, frequency of condomless receptive anal sex, frequency of condomless insertive anal 
sex with HIV-positive partners and use of amyl nitrate (“poppers”) and 
methamphetamines.25,26 Risk scores ranged from 0 to 45; higher scores point towards higher 
HIV risk.25,26 
  The predictor under investigation is resilience; measured using the Connor-Davidson 
Resilience Scale (CD-RISC-10), a 10-item Likert scale that measures a person’s ability to 
cope with adversity, and may promote better health outcomes and serve as a protective factor 
against HIV.13,17 Items included: “I am able to adapt to change”, “I tend to bounce back after 
illness or hardship”, and “I think of myself as a strong person”. Study participants were asked 
to rate their agreement with each item on a 5-point scale ranging from “not true at all” to 
“true all the time”. Answers were coded 0 to 4 and summed to obtain total CD-RISC score, 
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ranging from 0 to 40, with higher scores depicting higher resilience. The Cronbach’s alpha 
for the CD-RISC in the current sample was 0.87, suggesting high internal reliability.27  
  Other variables of interest for the current study included demographic characteristics, 
sexual heath factors related to HIV risk and HIV testing, and other psychosocial factors, such 
as internalized homophobia and social support. Demographic characteristics measured in the 
enrollment survey included age, race/ethnicity, sexual identity (e.g., gay, bisexual), 
employment status, highest level of education, annual income, health insurance status, and 
having performed sex work in the past 3 months. Sexual health variables included HIV 
testing frequency, prior use of PrEP, insurance status, and STI diagnosis in the past year. 
internalized homophobia (IH) assessed using the internalized homophobia 14-item scale. The 
IH scale answers ranged from Strongly disagree (1) to Strongly agree (4), with higher scores 
indicating higher internalization of homophobia. Perceived social support was scored using 
the 12-item Multidimensional Scale of Perceived Social Support.28  The perceived social 
support scale answers ranged from Very strongly disagree (1) to Very strongly agree (6), with 
higher scores indicating higher perceived support. The Cronbach’s alpha for the IHP and 
perceived social support scales in the current sample were 0.88 and 0.94, respectively, 
suggesting high internal reliability.27  
Analysis 
  Our objective was to explore the association between resilience and HIV risk among 
our sample of MSM. Descriptive statistics were used to describe the sample (n = 6,118). 
Socio-demographic differences in mean resilience were calculated using ANOVA. Bivariate 
associations between resilience and HIV risk, and other psychosocial variables were 
determined using the Pearson’s correlation (r). Finally, we assessed the association between 
resilience and HIV risk using multiple linear regression, adjusted for age, race, sexuality, 
income employment status, current health insurance status, HIV testing frequency, PrEP 
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status, STD diagnosis, IH and Social support.  Statistical significance was set at the 0.05 
level. All analyses were conducted using SPSS 26. 
 
RESULTS 
  Descriptive statistics for socio-demographic characteristics are presented in Table 3.1. 
Participants (n = 6,118) had a mean age of 30.6 years (SD = 7.9). Participants identified as 
white (52.2%), Hispanic/Latino (24.6%), Black (11%), multiracial (8.7%) and Asian/Pacific 
Islander (3.5%). The majority identified as Gay, Queer or Homosexual (85%) and did not 
have a main sexual partner (73.3%). Nearly two-thirds (62.6%) reported being fully 
employed, 45% reported having some college education, 41.7% reported an annual income 
between $20,000 and $49,999, and 48.4% lived in southern states of the U.S. A quarter 
(27.4%) reported that they did not have/were unsure if they had health insurance, 14.6% 
reported engaging in transactional sex in the past 3 months, and 14.2% reported prior, but not 
current, use of PrEP. Finally, over half self-reported as HIV-negative (58.2%), one-quarter 
(26.3%) reported that their last HIV test was more than a year ago. 
  The mean resilience score in this sample was 28.97 (SD = 6.07, Median = 29, Inter-
quartile range = 25, 33). Socio-demographic differences in mean resilience are also presented 
in Table 3.1.  There was a significantly higher mean resilience (p < 0.001) among those 
identifying as black, with higher education, having full-time employment, having an annual 
income of $50,000, having health insurance, being HIV-negative, and having tested in the 
last year. Moreover, there was a significantly lower mean resilience (p < 0.001) among those 
engaging in transactional sex in the last 12 months and among those having been diagnosed 
with an STD in the last 12 months. 
 Table 3.2 displays the correlation matrix between the predictor, outcome and 
variables of interest. The mean score on the IH and perceived social support scales were 
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26.65 (SD = 7.9) and 50.45 (SD = 14.02), respectively. Although weak, there was a 
statistically significant negative correlation between resilience and IH (r = −0.16, p < 0.001). 
We found a moderate and statistically significant positive correlation between resilience and 
social support (r = 0.30, p < 0.001). Nonetheless, there was no statistically significant 
relationship between resilience and our measure of HIV risk (MSM risk Index, r = -0.024). 
There was a statistically significant negative correlation between IH and social support (r = -
0.23, p < 0.001). Moreover, there were weak but significant negative correlations between IH 
and HIV risk (r = -0.04, p <0.01), and between social support and HIV risk (r = -0.09, p < 
0.001).  
Table 3.3 displays the results of the adjusted multiple linear regression between 
resilience and three models of HIV risk; Model 1 using the composite MSM risk Index 
measure, Model 2 using only a measure of condomless receptive anal sex, and Model 3 using 
a measure of condomless insertive anal sex. In model 1, there was no statistically significant 
association between resilience and HIV risk (β = 0.02 [95% CI: 0.02, 0.06]) after adjusting 
for age, race/ethnicity, sexual identity, education, income, employment, insurance status, HIV 
testing frequency, PrEP status, Internalized homophobia and perceived social support. In 
model 2, there was a statistically significant association between resilience and condomless 
receptive anal sex (β = -0.10 [95% CI: -0.17, -0.04], p < 0.001). Finally, in model 3, there 
was no statistically significant association between resilience and condomless insertive anal 
sex (β = -0.01 [95% CI: -0.05, 0.03]). 
 
DISCUSSION 
  In this study of geographically and racially diverse GBM, we did not find a significant 
association between resilience and our composite measure of HIV risk. We did, on the other 
hand, find a statistically significant negative association between resilience and reported 
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number of condomless receptive anal sex acts with male partners. We found higher resilience 
scores among younger participants, those identifying as black, with higher levels of education 
and income, and among those employed full-time. We also found statistically significant 
association between mean resilience and several health seeking behaviors such as testing for 
HIV in the last year and having health insurance. The average resilience score in our sample 
was lower than the average scores in U.S. community samples29-31 but slightly higher than 
those from sexual minority samples using the same resilience measure (CD-Risc-10).32,33  
  To our knowledge, this study is one of few studies assessing the relationship between 
resilience and HIV risk in a national sample of GBM. Other studies focusing on resilience 
frameworks in this population have found conflicting evidence between reduced HIV risk 
behaviors and resilience. McNair et al.  in their 2017 study of resilience and HIV risk 
behaviors among black GBM, found that participants with higher resilience scores had a 
lower prevalence of condomless anal sex with main and casual sexual partners.17 In a 2016 
study of GBM using sexual networking websites, White Hughto et al.  found that HIV-risk 
resilience was common and may manifest in safer sex intentions, such as sero-sorting and/or 
insisting on condom use.34 Meanwhile, Dawson et al.’s study on black GBM found no 
association between greater resilience and fewer instances of condomless anal sex.35  
Our findings do not confirm the proposed protective benefit of resilience on HIV risk as 
measured by the MSM risk index.  
 There are several factors explaining why our findings differ from those of the 
literature. First, the conceptualization of resilience as a unidimensional construct may be 
inadequate for this population. The Connor-Davidson Resilience scale only measures 
adaptability and coping, and although this is an acceptable construct to measure, resilience 
may be better conceptualized as a multi-dimensional factor, vis-à-vis syndemics. For 
instance, Wilson et al. conceptualized resilience	as	self-efficacy, hardiness/adaptive coping, 
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and social support, and found that self-efficacy and hardiness/adaptive coping may play a 
more important role in protecting young GBM from risks compared to social support.36 They 
found resilience to be associated with better psychological functioning factors (i.e., 
attachment, internalized homophobia, familism) that contribute to lower HIV risk among 
GBM.36 In their study of Tanzanian GBM, Adeboye et al. conceptualized resilience as 
structural and functional social support, age of sexual debut and social visibility, and were 
found to directly associated with lower odds of contracting HIV infection.37 Particularly, they 
conclude that participants with high social visibility had lower odds of HIV infection, even 
under the effect of multiple syndemics.37 Moreover, Dacus re-conceptualized resilience 
theory for black GBM as the intersection of self-agency, social support, and behaviors of 
avoidance of sero-conversion.38  
  Given this, our study may have been limited in its ability to fully measure resilience 
and could have accounted for our non-significant findings. Future research may benefit from 
assessing HIV risk through the presence of resilience-promoting (e.g., social support, 
hardiness and coping, etc.) or resilience-diminishing (e.g., internalized homophobia) factors. 
For example, we found a negative association between social support and HIV risk, and it 
may be more reliable to assess the presence of factors associated with resilience (e.g., social 
support) and look at the association between the numbers of factors present and HIV risk. 
Thus, offering a more comprehensive assessment of resilience.  
  Second, although the MSM risk index is a validated tool used to determine risk, it 
may have oversimplified men’s risk. The scoring schema for this tool requires assigning a 
number for each risk category that the participant has displayed. For instance, if a participant 
has engaged in condomless receptive anal sex more than once in the last six months, they are 
assigned a 10, regardless if they only had one occasion or five.26 As such, any variability in 
risk may have been masked by the grouping of HIV risk factors into one score.  Our findings 
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reflect this issue; when looking at the relationship between resilience and condomless 
receptive anal sex occasions (specific behavior), we found a significant negative association. 
Thus, it may be more appropriate to assess these relationships through the specific risk 
behaviors than a composite risk profile. 
 Although our main findings showed no significant association, there was a significant 
positive association between resiliency and social support, and negative association between 
resiliency and internalized homophobia. Formative research on the role of social support has  
Highlighted the need for strategies that enhance social support networks and address the 
social-psychological, emotional, and interpersonal factors, such as internalized and perceived 
homophobia that contribute to HIV risk.12,35,39 Future research is pivotal towards 
understanding how these interpersonal factors affect risk behaviors.  Our findings highlight a 
need to identify and promote health-enhancing positive factors in HIV intervention work.  
Limitations 
  Our findings should be interpreted through careful consideration of its limitations. 
First, the cross-sectional design of this study prevents making any conclusive causal claims 
about the temporality and directionality of the relationships we observed. This study was not 
designed to prove causation, only to correlate, and therefore causal inferences should be 
interpreted with caution.27 Although this fully online study allowed for increased 
geographical reach, it also increased the potential for fraudulent participants.40,41 Further, this 
study relied exclusively on data from self-reported surveys and, while measures to increase 
the validity of the data were put into place, social desirability and recall bias may have 
affected the study findings.42 Further, the study population was recruited via sexual 
networking apps and represented a sample of those at highest risk for HIV, who are not on 
PrEP at enrollment. Given the non-probability sampling, we are unable to generalize these 
results to other GBM. Our findings are limited to a sample of HIV-negative cis-gender GBM 
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and we cannot rule out that there may be unique differences in resilience profiles for 
individuals who are gender non-conforming and those who are HIV-positive. In fact, future 
research could benefit from exploring the role of resilience among HIV-positive individuals 
and in identifying resilience enhancing factors.  
  The persistent racial disparities in HIV infection warrants the need to collect and 
examine more data beyond behavioral factors. Particularly, there is a need to understand 
pervasive social influences and structural determinants of HIV risk among minority GBM.  
Our findings provide alternative prospects to pursue regarding the effects of social factors of 
racial disparities in HIV risk among GBM. 
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Table 3.1. Socio-demographic and health behavior characteristics of the Together 5,000 cohort by mean resilience, n = 
6,118 
Characteristic M SD    
Age 30.60 7.90    
Resilience (CD-Risc) 28.97 6.07    
  Frequency % Mean CD-Risc ANOVA (F) p-val* 
Race/Ethnicity      
 White 3191 52.2 28.9 9.60 < 0.001 
 Black 674 11.0 30.2   
 Latino 1505 24.6 28.8   
 Asian/Pacific Islander 217 3.5 27.8   
 Multiracial 531 8.7 29.0   
Sexual Orientation      
 Gay, Queer, Homosexual 5198 85.0 29.0 0.16 0.851 
 Bisexual 864 14.1 29.0   
 Other 56 0.9 28.6   
Education      
 < High school diploma 139 2.3 27.7 8.00 < 0.001 
 High school diploma or GED 869 14.2 28.2   
 Some college or technical school training 2752 45.0 29.1   
 College graduate + 2358 38.5 29.2   
Employment Status      
 Full-time (40 hours per week) 3831 62.6 29.5 30.78 < 0.001 
 Part-time (less than 40 hours per week) 785 12.8 28.2   
 Working- or full-time student 492 8.0 28.8   
 Unemployed/Other 1010 16.5 27.7   
Annual Income      
 Less than $20,000 2014 32.9 28.0 48.38 < 0.001 
 $20,000-$49,999 2554 41.7 29.2   
 $50,000+ 1550 25.3 29.9   
Has a main partner      
 Yes 1634 26.7 28.9 0.60 0.44 
 No 4484 73.3 29.0   
Health Insurance      
 Yes 4443 72.6 29.1 13.30 < 0.001 
 No/do not know 1675 27.4 28.5   
Engaged in sex work (past 12 months)      
 Yes 895 14.6 28.1 21.80 < 0.001 
 No 5223 85.4 29.1   
Self-reported HIV Status      
 HIV-negative 3559 58.2 29.5 59.71 < 0.001 
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 I don't know; I am unsure 2559 41.8 28.3   
Have you ever been tested for HIV?      
 In the past 12 months 3746 61.2 29.3 10.64 < 0.001 
 More than a year ago 1612 26.3 28.5   
 Never 760 12.4 28.5   
Prior PrEP use      
 Yes 871 14.2 29.0 0.003 0.958 
 No 5247 85.8 29.0   
Diagnosed with an STD in the last 12 Months      
 Yes 1087 17.8 28.3 14.22 < 0.001 
 No 5031 82.2 29.1   
Region      
 Northeast 911 14.9 28.5 1.81 0.123 
 Midwest 887 14.5 29.1   
 South 2950 48.4 29.1   
 West 1323 21.7 29.1   




Table 3.2. Correlation Matrix between Psychosocial variables, Resilience and HIV Risk 
Variables Mean SD 1 2 3 4 5 6 
1. Internalized Homophobia 26.65 7.90 - -0.23
† -0.16† -0.03* -0.002 -0.04** 
2. Social Support 50.45 14.02   - 0.30
† -0.04** -0.03* -0.09† 
3. Resilience (CD-Risc) 28.97 6.07     - -0.06† 0.003 -0.024 
4. Condomless Receptive Anal Sex Acts with Male 
Partners in the last 3-momths 
4.20 8.00       - 0.27** 0.26† 
5. Condomless Insertive Anal Sex Acts with Male 
Partners in the last 3-momths 
4.30 7.90         - 0.31† 
6. MSM Risk Index 18.75 7.86           - 
*p < 0.05; **p  < 0.01; †p  < 0.001 
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Table 3.3. Multiple Linear Regression of HIV Risk and Resilience (CD-Risc) 
  
  Model 1: Composite Risk (MSM Risk Index) Model 2: Condomless Receptive Anal Sex Acts with Male Partners in last 3-Months 
Model 3:  Condomless Insertive Anal Sex 
Acts with Male Partners in last 3-Months 
  b SE 95% CI b SE 95% CI b SE 95% CI 
Age -0.20** 0.02 (-0.23, -0.17) -.003 0.03 (-0.05, 0.05) .09† 0.02 (-0.05, 0.12) 
Race/Ethnicity                   
White Ref - - Ref - - Ref - - 
Black -1.87† 0.38 (-2.61, -1.13) -1.9 0.61 (-3.10, -0.70) -0.79 0.41 (1.58, 0.01) 
Latino -0.90** 0.28 (-1.44, -0.35) 0.42 0.45 (-0.47, 1.30) -0.11 0.30 (-0.70, 0.47) 
Asian/Pacific Islander -1.76** 0.60 (-2.93, 0.59) -0.81 0.96 (-2.70, 1.10) -2.35† 0.64 (-3.60, -1.10) 
All Other Multi -0.43 0.41 (-1.23, 0.364) -0.56 0.66 (-1.80, 0.73) 0.72 0.44 (-0.14, 1.60) 
Sexual Identity                   
Not Gay Ref - - Ref - - Ref - - 
Gay 1.35† 0.34 (0.69, 2.02) 1.51** 0.55 (0.43, 2.60) -1.61† 0.37 (-2.33, -0.90) 
Education                   
Less than College Ref - - Ref - - Ref - - 
College Graduate -1.16† 0.24 (-1.63, -0.70) -0.33 0.39 (-1.10, 0.43) -0.15 0.26 (0.65, 0.36) 
Income                   
More than 20,000 a year Ref - - Ref - - Ref - - 
Less than 20,000 a year .08 0.28 (-0.48, 0.64) 0.06 0.46 (-0.84, 0.95) -0.21 0.30 (-0.80, 0.39) 
Employment                   
Unemployed Ref - - Ref - - Ref - - 
Employed -1.74† 0.33 (-2.40, -1.10) -2.27† 0.54 (-3.32, -1.22) -0.46 0.36 (-1.16, 0.24) 
 70 
Insurance Status                   
Uninsured Ref - - Ref - - Ref - - 
Insured -1.77† 0.27 (-2.30, -1.25) -0.44 0.43 (-1.28, 0.40) -0.61* 0.29 (-1.17, -0.05) 
HIV Testing Frequency                   
Less than every 3 months Ref - - Ref - - Ref - - 
At least every 3 months 0.59 0.32 (-0.41, 1.23) -0.86 0.52 (-1.90, 0.16) 0.44 0.35 (-0.24, 1.12) 
PrEP Status                   
Never used PrEP Ref - - Ref - - Ref - - 
Used PrEP previously 1.84† 0.30 (1.25, 2.42) 0.98* 0.48 (0.04, 1.92) 0.75** 0.32 (0.13, 1.40) 
STD Diagnosis                   
More than a year ago Ref - - Ref - - Ref - - 
In the last year 1.53† 0.28 (0.98, 2.10) 2.36† 0.45 (1.50, 3.25) 1.14† 0.30 (0.55, 1.73) 
Internalized Homophobia -0.05** 0.02 (-0.08,-0.02) -0.06* 0.03 (-0.10, -0.01) -0.01 0.02 (-0.05, 0.02) 
Social Support -0.05† 0.01 (-0.06, -0.03) -0.02 0.01 (-0.04, -0.01) -0.01 0.01 (-0.03, 0.004) 
Resilience (CD-Risc) 0.02 0.02 (0.02, 0.06) -0.10† 0.03 (-0.17, -0.04) -0.01 0.02 (-0.05, 0.03) 
*p < 0.05; **p  < 0.01; †p  < 0.001 
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CHAPTER 4 – ENGAGEMENT IN CARE AMONG NEWLY DIAGNOSED HIV-
POSITIVE GAY, BISEXUAL AND OTHER MEN WHO HAVE SEX WITH MEN IN 
THE UNITED STATES: RESULTS FROM THE TOGETHER 5,000 STUDY. 
 
ABSTRACT 
Background: Despite many efforts, one-quarter of HIV-positive gay, bisexual and other men 
who have sex with men (GBM) are not engaged in HIV care. Retention in HIV care improves 
health outcomes and reduces the risk of transmission. As such, it is necessary to understand 
factors that influence linkage and engagement in HIV care. 
 
Methods: In 2018-2019, 50 GBM completed qualitative interviews 3-months after receiving an 
HIV-positive result while taking part of Together 5,000, an U.S. national cohort of men, 
transgender women and transgender men who have sex with men. Interviews explored the 
barriers and facilitators to engagement with HIV testing and care.  
 
Results: Participants had a mean age of 31.7 years (SD = 8.0). Forty-eight percent were white, 
16% were black, 28% were Latino, and 8% were mixed race. Almost half (46%) were uninsured 
and did not have a primary care provider (48%). The majority (94%) of participants reported 
being linked-to-care, while only 74.5% of those reported initiating ART. Thematic analysis 
identified 4 major themes related to participants’ engagement in care: 1) Reasons for HIV testing 
(e.g., HIV self-testing and expectation of positivity), 2) Linkage-to-care (e.g., 
appointment/logistic issues and social support as encouragement), 3) Barriers (e.g., financial 
burden, competing priorities and fear/stigma) and facilitators (e.g., financial assistance, patient-
provider relationships, auxiliary support services and health agency) to engagement in HIV care, 
and 4) PrEP as a missed prevention opportunity.  
 
Conclusion: Addressing policy-, social- and individual-level barriers could improve GBM’s 
engagement in HIV care. Further, capitalizing on GBM’s health agency through partnerships 
with local agencies and fostering better patient-provider relationships could optimize continuity 




  HIV continues to be a pervasive public health issue in the United States (US).1,2 Gay, 
Bisexual and other men who have sex with men (GBM) accounted for over two-thirds (27,000, 
70%) of all new HIV diagnoses in 2017, thus warranting continued efforts for prevention and 
intervention.2-6 As such, officials across the US have adopted a concerted commitment towards 
Ending the HIV Epidemic (EtE), with an established goal to reduce the number of new HIV 
infections through combination efforts, including treatment as prevention, Pre-exposure 
prophylaxis (PrEP), and HIV testing with timely linkage-to-care.7 Successful and prolonged 
engagement in HIV care, including antiretroviral therapy (ART), not only reduces forward HIV 
transmission and leads to improvements in morbidity and mortality associated with HIV/AIDS-
related illnesses but also improves overall health and quality of life.8-15 Health policies, like the 
HIV Continuum of care, can be effective tools for monitoring the progress of HIV prevention 
and intervention strategies in order to achieve the UNAIDS 90-90-90 goals to end the 
epidemic.16,17 Moreover, the HIV continuum of care underscores the importance of viewing HIV 
prevention as a dynamic event requiring ongoing engagement and retention for as long as the 
individual remains at risk.18 This paradigm shift allows for tracking and understanding missed 
prevention opportunities; while considerable progress has been made in detecting new HIV 
cases, difficulties remain in maximizing prevention for those at-risk and in streamlining linkage-
to-care for those diagnosed with HIV, especially in hard-to-reach sexual minority 
populations.16,17,19,20  
  Particularly, the US is failing to meet viral suppression targets and there are large gaps in 
the HIV continuum of care for GBM. In 2015, the White House released its National HIV/AIDS 
Strategy (NHAS) with a goal to ensure that 90% of all people living with HIV (PLHIV) are 
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retained in care and 80% of all PLHIV are virally suppressed by 2020.21 According to the CDC’s 
2016 HIV Surveillance Report, 85% of PLHIV in the US have been diagnosed, 63% have been 
linked to care, 48% are retained in care, and 49% are virally suppressed.22 Further, they estimate 
that 5 in 6 (83%) GBM were diagnosed with HIV, 72% were linked to HIV care, 57% were 
retained in care, and 58% had a suppressed viral load. Studies have also reported racial and 
ethnic disparities in HIV treatment outcomes. Data from the National HIV Behavioral 
Surveillance (NHBS) found that black GBM were faring significantly worse across all steps of 
the HIV treatment continuum compared to white and Latino GBM, even after controlling for 
other confounding variables.23,24 For instance, PrEP awareness, willingness, and uptake were 
significantly lower among racial/ethnic GBM despite their higher HIV incidences compared to 
white counterparts.25 Therefore, additional research is needed to better understand the barriers 
and facilitators to successful engagement in HIV care.  
  Existing research suggests that medical mistrust, stigma, and discrimination due to sexual 
orientation act as barriers to engagement in care.13,26-28 While these factors impede the adequate 
formation of a positive patient-provider relationship, which is pivotal for optimal engagement 
and retention in care, little is known regarding the factors that could facilitate prolonged 
engagement, especially among disenfranchised communities.11,29-31 Moreover, there are limited 
qualitative findings regarding where and why fall-outs occur for individuals in resource-limited 
geographic settings.10,12,29,32 GBM of color are a particularly vulnerable population warranting 
special attention due to increasing HIV prevalence rates and their susceptibility for fall-outs from 
care.33,34  
  This study explored how a sample of 50 recently HIV-diagnosed GBM from across the 
US were linked to care and how they continue to be engaged in care through qualitative in-depth 
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interviews. Particular attention was given to the challenges participants faced with their linkage-
to-care and initiation of ART. The goal of this study was to identify barriers and facilitators to 
timely linkage-to-care, as well as missed opportunities for HIV prevention and intervention.  
METHODS 
Cohort recruitment, enrollment, and surveys  
  This study used data collected as part of the Together 5000 study, a U.S. national, 
internet-based cohort study of cisgender men, transgender men, and transgender women who 
have sex with men in the US. The overall goal of the study was to identify modifiable individual 
and structural factors associated with HIV seroconversion and PrEP uptake. Enrollment began in 
October 2017 using ads on men-for-men geosocial sexual networking phone applications and 
concluded in June 2018. Participants were eligible if they identified as cisgender men, 
transgender men, or transgender women; were between the ages of 16 and 49; had at least 2 male 
sexual partners in the last 3 months; were not currently participating in an HIV vaccine or PrEP 
clinical trial; were not on PrEP at the time of enrollment; lived in the US or its territories; self-
reported their HIV status as HIV-negative or unknown; and met at least one of the following 
additional criteria: diagnosed with syphilis or rectal gonorrhea/chlamydia in the last 12 months, 
shared injection drug use needles in the past 12 months, self-reported more than one receptive 
CAS acts with a man in the past 3 months, self-reported greater than two insertive CAS acts with 
a man in the past 3 months, took post-exposure prophylaxis (PEP) in the past 12 months, and/or 
self-reported methamphetamine use in the past 3 months. While the recruitment strategies were 
targeted to reach GBM, our enrollment criteria did not exclude transgender men and transgender 
women who otherwise met study criteria. Nonetheless, transgender men and women were not 
enrolled in this qualitative study because they experience unique patterns of engagement in HIV 
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care that are distinct to GBM. A full description of the recruitment methods and of the Together 
5,000 cohort have been previously published.35,36 
  Participants completed the informed consent and enrollment survey through a secure 
webpage. Those eligible were later sent a link (email and text) to complete a secondary survey 
that collected additional behavioral data. Of those who completed the enrollment survey, 8,755 
participants met eligibility criteria. These participants were invited to complete a baseline online 
survey via email. Of those, 6,267 (71.6%) completed the baseline survey and received a $15 
incentive.35,36 Following completion of the survey, participants were mailed an OraSure HIV-1 
specimen collection device for self-testing. After completion of the oral swab, participants were 
instructed to mail the specimen using a prepaid shipping envelope addressed to the New York 
State Department of Health (Avioq HIV-1 Microelisa System). We successfully delivered 6,150 
HIV test kits to participants, 5,065 of which were returned by the lab, and 195 identified as pre-
liminary positives. Participants were not told in advance how they would be contacted to receive 
their results. HIV-negative results were sent to participants via email. Preliminary HIV-positive 
results were delivered to participants via phone. Delivery of HIV-positive results followed an in-
house protocol that included provision of referrals to local healthcare resources to facilitate 
confirmatory testing and linkage-to-care. The protocol and findings of the delivery of positive 
results over the phone have been previously published.37 Among participants with a preliminary 
HIV-positive result, 68% (n = 132/195) were successfully delivered to participants through 
telephone. Participants who did not receive their results were discreetly contacted multiple times 
via phone and email. Voicemails and emails from staff indicated our desire to speak with them 
but did not specify the reason or reference their test results. Participants who successfully 
received a test result by phone were eligible to participate in the qualitative in-depth interview 
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(IDI).  
Qualitative In-depth Interviews 
  In total, 132 participants were invited to participate in the qualitative IDI. Invitations 
were sent by email approximately three months after delivery of their preliminary positive test 
results. Participants were invited to participate, and those who expressed interest were consented 
and enrolled in the study. MS, JLR and CG conducted one-on-one, semi-structured, audio-
recorded phone interviews between March 2018 and January 2019. During data collection, 
interviewers took notes and met regularly to compare themes to determine saturation. Once the 
interviewers felt confident that data saturation had been achieved, we ceased recruiting 
additional participants. In total, 54 participants completed a qualitative interview; however, four 
interview recordings were lost due to audio file corruption, leaving an analytic sample of 50 
interviews. Participants provided verbal informed consent, completed the 60-minute interview, 
and were given a $40 incentive for their time. These procedures were reviewed and approved by 
the Institutional Review Board at The City University of New York’s Graduate School of Public 
Health and Health Policy.  
Measures 
  Descriptive demographic and behavioral characteristics were derived from data collected 
as part of the enrollment and secondary survey. The IDIs were conducted via phone and followed 
a semi-structured interview guide (Appendix C). The interview guide was developed and based 
on the socio-ecological model in order to identify individual and structural factors to engagement 
in care. The qualitative interview explored participants’ experiences with linkage to and retention 
in HIV care, initiation of ART, as well as any barriers and facilitators to their engagement with 
HIV testing and care. Further, participants were asked about their recent history of HIV/STI 
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testing and their knowledge of PrEP and PEP prior to their diagnosis. Participants were also 
asked to provide feedback about their experience receiving a preliminary HIV-positive result by 
phone, along with any concerns they had about that process. In this paper, we present data on 
participants’ engagement with HIV testing and care. 
Data Analysis 
  Recordings were transcribed verbatim and transcripts were verified against audio 
recordings to ensure quality control. The conceptual framework for this analysis was rooted in 
the socio-ecological model (SEM) which allowed us to explore the complex interplay of multi-
level factors influencing engagement in HIV care.38 Further, an inductive, thematic approach was 
used to analyze participants’ experiences in HIV Care.39 The first author performed an initial 
close read of 20% of the transcripts, during which initial codes were identified inductively and 
categorized thematically.40 The first author (JLR) coded all transcripts, and the second author 
(CL) independently reviewed the codebook containing coded excerpts from transcripts, 
highlighting content and noting any overlap or discrepancies between the excerpts and their 
codes. The first author also reviewed coded transcriptions for overlap and discrepancies. 
Throughout the coding process, the first and second author adjusted the codebook to reflect 
emergent data from the transcripts. Any discrepancies were discussed with the coding team until 
consensus over the application of each code was reached.  
RESULTS 
Descriptive statistics for socio-demographic characteristics are presented in Table 4.1. 
Participants (n = 50) had a mean age of 31.7 years (SD = 8.0). Forty-eight percent of participants 
were white (n = 24), 16% were black (n = 8), 28% were Latino (n = 14), and 8% were mixed 
race (n = 4). All participants identified as cisgender male with most (94%, n = 47) identifying as 
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gay, queer, or homosexual and a minority as bisexual (6%, n = 3). The majority reported having 
some college education (58%, n = 29) or a college degree (28%, n = 14). About half reported 
working full-time (54%, n = 27) and an annual income of less than $20,000 USD (44%, n = 22). 
At baseline, about half of participants (46%) were uninsured and did not have a primary care 
provider (48%). Further, almost two-thirds (62%, n = 31) lived in southern states of the US. 
Thematic analysis identified four themes and several sub-themes related to participants’ 
engagement in care: 1) Reasons for HIV testing, 2) Linkage-to-care, 3) Barriers and facilitators 
to engagement in HIV care, and 4) PrEP as a missed prevention opportunity. Exemplary quotes 
accompany each theme.  
Reasons for HIV testing 
Thirty-four percent of participants reported testing for HIV within a year prior to 
enrollment, 52% more than a year prior, and 14% said they had never tested for HIV. Seventy-
two percent of participants self-reported being unsure of their HIV status at the time of 
enrollment. During IDIs, participants detailed their reasons for testing through the study. Two 
salient reasons emerged from their accounts: 
Increased access through HIV self-testing 
Many of the participants noted that they joined the study for the ability to test for HIV in 
the comfort and privacy of their homes. Most expressed not having tested in a significant amount 
of time and reported that the study allowed them to test without having to take time off to visit a 
clinic or a doctor. Some participants preferred this method because they had limited access to 
testing sites or local clinics were a significant distance from their home. 
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I felt like it was a whole lot better because like I didn't have to, you know to go be around 
anyone really. I just do it in the comfort of my home, send it off, and then you gonna get 
the results over the phone and I knew you can't do that, well I mean, I could, usually you 
have to go in to do that, but I didn't have to come in for the results its all over the phone. 
So that's, you know, I do like that a whole lot more, you know just be in the comfort of my 
home and it's either a phone call or I call in to get results. (28 years, black, Mississippi) 
“I think that what you all are doing is really cool. I think that, you know, doing HIV tests 
like you all are doing, giving them to people whose thinking, you know, people who might 
not, maybe wouldn't, wouldn't want to go to an HIV clinic.” (28 years, white, Louisiana) 
“I live on an island so there’s only one hospital I could go to. The reason why I got a 
mailed test from you guys is because I was scrolling Facebook, saw the ad, and it had 
been a while since I had gotten tested… so at the time I didn’t have health insurance so I 
couldn’t go to the clinic here so that’s why I got the test. It had been a long time, maybe a 
year that I had been tested prior to that so it was definitely time.”   
(30 years, multiracial, California) 
“Part of what was interesting about this study was, I was thinking of going on PrEP. 
Because here we do testing before you get on PrEP. So I was like well let's just do it. And 
I really don't wanna walk into a clinic... I don't like going to the doctors offices period.” 
(28 years, black, Hawaii) 
 
Expectation of Positivity 
Another widely cited reason for seeking testing through our study was that participants believed 
they were HIV-positive but had no confirmation of their status. Many disclosed significant 
sexual risks over the past year and reported feeling that they were expecting a positive diagnosis 
at any point. Participants noted that the study afforded them the opportunity to get tested at home 
on their own time.   
“Another reason I was looking at the study was not just out of curiosity, because I 
actually hooked up with a guy who I then found out was positive. I was much more 
worried than I thought, so I had a feeling. Uh, I, I had an, it was just weird. I had a 
feeling, um, that something had changed. That there was a possibility, a higher, uh, 
possibility suddenly.” (47 years, white, Connecticut) 
“Most definitely but um, there was always something in the back of my mind. That it 
would be nice to know. It would be nice to know.” (27 years, white, Nevada) 
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“But the previous, the year prior to that I did find out that you know there was two people 
that I had intercourse with that were positive, you know granted I didn’t ask but they did 
divulge either. Yes, that’s why- that’s why I sent for the test from you guys.”  
(30 years, multiracial, California) 
“I kind of had a feeling before your all’s test or whatever, it’s like I figured that now okay 
let’s figure out now how to deal with it. Just my past, very, not necessarily promiscuous 
but doing what I had to do to you know survive.” (31 years, white, Alabama) 
 
Linkage-to-care 
At the time of the IDI, participants had received their preliminary HIV diagnosis an 
average of 4 months prior (Range [3, 7]). The majority (94%, n = 47) of participants reported 
being linked-to-care and had had their HIV diagnosis confirmed by a healthcare provider, while 
only three-quarters (74.5%, n = 35) of those reported initiating ART. Among those who had not 
sought care, two avoided making an appointment out of fear of their results and being confronted 
with the reality of their positivity, and one participant reported many competing priorities like 
moving, school, and loss of employment.  
“I had not really wanted to see that positive test result on paper. Just the reality of it. 
Ignore it, it goes away.” (44 years, white, Alabama) 
“Uh, I have not yet. I'm waiting on that. Um, mostly I'd say due to fear.” 
 (29 years, white, Texas) 
“No, not yet. It's a lot of trouble since then and I'm moving, school, I'm losing my job. So 
I really just, there's just been a lot going on but I just really haven't been able to.”  
(28 years, black, Mississippi) 
Thematic analysis of the data resulted in two salient themes related to linkage to care: issues with 
appointment scheduling or logistics and social support as encouragement to linkage. 
Issues with Appointment Scheduling or Logistics 
Although the majority of those in care reported little issues once they had been linked, 
most expressed difficulties in scheduling their initial appointments, being referred to places 
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outside their county, and only being able to reserve appointments that were scheduled weeks or 
months after their initial call. 
“I called them to set up the appointment, they said that I had to go to the one in the 
county that I was living in, and so then I called them but they didn't have any 
appointments because they only do testing on Tuesdays. So they referred me to a different 
clinic in a different county, and they got me in the same day to do the testing, confirmed 
everything, and signed me up with one of their doctors to start treatment” (26 years, 
white, California) 
“I then called [a doctor that was recommended] and then scheduled an appointment to 
be seen with that doctor. That took about, maybe two months. Yeah, before I got to be 
seen by the doctor, the infectious disease doctor.” (35 years, Latino, Texas) 
“Yeah, it took me a while ‘cause by the time like I had set up an appointment with my 
doctor, they said that the soonest would have been in about three to four weeks from the 
day. Um so I did end up going, and I did actually… you know make it to the appointment 
to get the confirmatory testing and everything, but it just took a while but I did actually 
go ahead and go through with that.” (24 years, white, California) 
 
Social Support as Encouragement to Linkage 
Some participants pointed to family and friends as sources of not only emotional but 
instrumental support after receiving their diagnosis. They articulated that their support system 
often offered words of solace during those difficult times, encouraged them to seek care, and at 
times, took them directly to a health clinic to get confirmatory testing.  
“Um, I had somebody that was already, uh, with them, that's a friend of mine… Um, 
pretty much is just like, "Okay, I need to go get everything taken care of." And he was 
like, "All right, well, I'll go ahead and make a call, get you an appointment to be seen 
with the caseworker and get your ... get everything going."” (35 years, white, Texas) 
“My aunt actually took me to the doctor. Then it came out positive. I was so scared. I was 
scared at first. I thought my life's going to end. But that afternoon I started talking with 
the counselors who told me about. Everything was good.” (22 years, black, Florida) 
“I do have a support team, and I was just like my support team they were just like, 
"Regardless of whatever happens, whatever you go through, we're still going to be here 
for you." So it was like, they kinda helped motivate and pushed me a little bit, pushed me 
 82 
towards going, 'cause I was, honestly I was really nervous about it, and I didn't think I 
was gonna go.” (27 years, black, Georgia) 
 
Barriers to Engagement in HIV Care 
Financial Burden 
Participants articulated finances as a major barrier to sustained engagement in HIV care. 
Participants who did not have insurance were forced to decide whether to hold off attending 
appointments or initiate ART and risk being billed for it later. In fact, participants often cited 
feeling uneasy regarding their lack of control over being able to pay for their care as well as all 
of the bureaucracy related to obtaining public assistance.  
“When they told me that, that it was gonna be a little bit expensive, I was like, okay, but I 
don't have like a really good job, so, basically, you have to have a- You have to be rich to 
have your medication, that was my first thought. But I seen, I mean, I, I had to find a 
way.” (29 years, Latino, California) 
“Two months [to get on ART]. I was kind of like – until I decided [to take it] the doctor 
recommended like just try right away. I didn’t have any income I didn’t have any – I think 
other than that my health was fine so that was my reason behind not getting on it 
immediately.” (40 years, Latino, Texas) 
“They said that I had to like go through – cause I – you know I’m a college student. I 
don’t have any money. So they got me, like I had to send off like a whole bunch of 
paperwork saying that like I don’t have income to pay for this medicine. And then, they 
said it would take like 6 weeks and that was like in May that they got me to like come 
back and do that. You know like that’s been the most difficult part is knowing that like I 
don’t have the medicine right now. Knowing that like it’s like attacking my body and then 
having to go fill out all these papers to like prove that I’m like poor enough you know. 
Like it’s, the process just takes so long that you just give up half way through you know.” 
(22 years, Latino, Texas) 
“What really got to me or made it difficult for me was my finance. I didn’t have the 
money to go see a doctor. I didn’t have the funds to actually pay for medication. And, and 
that scared me. That really scared me. In the sense that, what if I really do need 
medication and I’m to a point that I need medication now and I can’t afford it?”  
(29 years, Latino, Florida) 
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Competing Priorities 
The majority of participants cited a diverse array of social issues that they had to prioritize over 
their medical appointments. Specifically, several participants reported periods of unstable 
housing, which resulted in delays initiating ART or attending appointments. 
“I’m actually kind of homeless, my family is kind of there for me, I mean they’re there for 
me as much as they can be. I haven’t started medication yet, but I have met with my 
doctor and we’ve been talking about it and I should actually be starting medication for it 
probably within the next two, three weeks. By the time I get everything situated on my 
end.” (24 years, white, California) 
 
Others reported that their work or school schedules conflicted with appointments, often feeling a 
need to choose one over the other. In most cases, they did not attend their appointments and 
rescheduled them for later times, but for some this resulted in delays to receiving care.  
“Um, I think so. He's been trying to meet with me, but I just work a lot and don't really 
have time for it so he's always trying to speak with me. So I haven’t been able to see them 
again. I actually had an appointment yesterday, but unfortunately I wasn't able to make 
it.” (25 years, Latino, New York) 
“I would say the only thing that was inconvenient was because I had school and most of 
these doctor's offices or appointments in clinic are open, um, you know, when I get out of 
school and won’t be open when I could have a school. So I’ve had to take a lot of time at 
a school.” (18 years, black, Texas) 
A few participants cited moving as a reason for falling out of care. Participants expressed that 
their move resulted in concerns over how to re-engage in care, particularly that they did not 
know where to go and had little time to search for a provider.  
“My priorities were just not there. Which I completely regret, but they weren't there at 
the time. I just opened a business. I just moved. And so, I just had a lot going on and the 
last thing I had time to do was going to do that.” (29 years, multiracial, Pennsylvania) 
“I did not have health insurance. I just recently moved from another city. I left my job. I 
wasn’t feeling good, but I really thought a lot of it was just my job, that I was just really 
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that unhappy and stressed out but… but it wasn’t [getting care].”   
(39 years, white, Texas) 
“One of my big concerns when I first found out was just because, like, being in [different 
city] is just like... I didn't really have the healthcare I have here. And I was worried about 
getting the medication.” (27 years, Latino, New York) 
 
Fear and Stigma 
Some participants expressed feelings of fear and anxiety over visiting their doctors or clinics. 
Particularly, some participants were concerned with being recognized and outed for their status 
and sexuality. Others were concerned about societal stigma for being HIV-positive. Some 
articulated that a fear of their diagnosis contributed to their delay in getting engaged in care. 
“Well, I just have this fear of going to the doctors. So, usually anytime before even, but 
now it's like even worse. It takes me maybe three appointments before I actually show up. 
Because I just get such anxiety like the week before and then it just builds and builds and 
builds. 'Cause like I'm just waiting for them to tell me the next thing I'm dying from.” 
 (29 years, multiracial, Pennsylvania) 
“Sexuality, for people who are gay, is already such a negative connotation behind it 
that's there a constant fear. And so nobody runs for help, at least not really openly, 
especially not where I come from. So, that's one thing within itself.” 
 (25 years, Latino, North Carolina) 
“So I told myself, "Oh I'll be fine. I'll just, I'll just give myself a little time to think about 
it, and I'll see where I go from there." That was probably about maybe two months ago? I 
was just very stupid, I convinced myself that I'll be fine, I'll just let, I'll just let time run its 
course, and I'll just see what happens. Me thinkin' that way was 'cause I was afraid. 
Everything was kinda like hittin' me all at once. And then I still have to work, and I had 
to think about all these other things, it was just, it was just too much. 
(23 years, black, Texas) 
“My thoughts were well what if I ran into somebody that I know? It’s not that I don’t 
want to go but what if I’m just scared or chicken out? Once I got in, it was also just a 
little nerve wracking. You know to figure out what was going to happen to me then. How 
bad I was and how bad the situation was going to be or is.”  
(29 years, Latino, Florida) 
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Facilitators to Engagement in HIV Care 
Financial Assistance 
At the time of diagnosis, participants expressed concerns over their ability to pay for HIV care, 
with many citing financial hardships or lack of insurance. Similarly, participants widely cited 
financial assistance, either through government sponsored health insurance, drug assistance 
programs, or co-pay assistance programs, as the main reason they initiated ART and were able to 
afford care. In turn, some reported feeling relieved that clinic staff helped sign them up for 
financial assistance during their medical appointments. 
“They have a program, the state does, for people that aren’t working that … you get 
insurance and it’s good for as long as you’re not working. They pay for everything, 
doctor visits, they pay for one medication a month for like antibiotics stuff like that. It’s a 
separate program than what is paying for my Genvoya. That, I got a letter from the 
actual manufacturer saying that because of the situation I’m in, they will not charge me 
for it.” (39 years, white, Texas) 
“They signed me up while I was there. Gave me the information to go online to finish 
signing up, but basically had done all the work for me. They made sure that even my co-
pay is paid. I don't pay a dime and then they contact me every month just to verify my 
address and make sure that I'm not running out of pills earlier.”  
(47 years, white, Connecticut) 
“its called the Ryan White Program here. And luckily enough, the clinic that I go to, they 
accept and they actually got me enrolled in it and it covered all. ‘Cause you'd have $60 
copay with my insurance from work and it covered all that even that copay and then any 
other things like dealing with care. So, even like my eyesight, like, you know, I'm visually 
impaired. Um, so I'm in a program, but I mean, just seeing the amount of money that 
these pills are, um, before the deductible and some like you know, it’s like $2100 for a 30 
day supply and I'm on four medications that cost that each. So, its crazy, it's America. 
And you know the pills that we have from these companies are ridiculous, but I just, I 
mean, if someone didn't have insurance or the program like I did, there's no way you'd be 
able to afford these.” (30 years, white, North Carolina) 
 
Kind, Comforting, and Thorough Providers  
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Participant interactions with HIV care providers had a significant impact on engagement in care. 
Good communication, kindness, reassurances, and thoroughness in care were essential to 
consistent engagement, whereas not feeling respected, cared about, or listened to were reasons 
for disengagement. Participants also cited the importance of providers who were invested in their 
health and communicated well, preferring providers who thoroughly explained treatment options 
and addressed their concerns. 
“The doctor is very, very nice. For anybody who's going through this, you don't-- 
obviously I didn't want to tell anybody, it's like something personal, and obviously at the 
very beginning, it's very hard, you need an outlet but you don't know who to talk to. And 
so, when I talked to the doctor I felt like, it's somebody that I could- obviously 
understands my situation. And I had all these questions and he was able to kind of 
answer them. And then put my ... put my mind at ease, not to be so stressed about it.” 
 (35 years, Latino, Texas)  
“It was a little bit confusing trying to find the right clinic at the very beginning you know, 
when you're stressed out and everything. But, um, actually everyone I talked to was super 
nice, super helpful. Um, the clinic is probably the part that impressed me the most, 
because they were just like, on top of everything. Trying to make it as quick as possible.” 
(26 years, white, California) 
“I was very surprised by how understanding and how nice people were and how helpful 
it was. It was very kind of shocking. Because you go in you know with this preconceived 
notion how it might go or whatever. People were super nice, super helpful. They were 
informative and it made me feel kind of at ease about the whole situation.”  
(26 years, Latino, Texas) 
 
Auxiliary Support Services 
A salient aspect of participants’ narratives was the importance of having available, 
comprehensive auxiliary social services. Participants reported that these services acted as 
facilitators to engaging and, more importantly, being retained in care. In most cases, these 
services included: support groups, mental health services, transportation assistance, medication 
delivery, and housing assistance.  
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“They're going to try to help me with subsidized rent. Um, also they helped me with 
transportation, as far as getting back and forth to my appointments so I don't have the 
worry about stuff like that or if I can’t ever make an appointment. And they was willing to 
work with me like, just whatever help I needed to make sure I make my appointments so 
there's never a reason that I'm not able to get my medicine or appointments or stuff like 
that. And then, I like the fact that sometimes, 'cause I work a lot, so I was like, if I'm not 
able to pick up my medicine, they do deliver it to me in the mail so that works for me also. 
So when I get off, I still ... there's no excuse or no reason not to have my medicine.”  
(27 years, black, Georgia) 
“I got it pretty easy. I mean, if my car breaks down, they can, um, I can call them and 
they would actually come pick me up. Um, I have my ... the meds delivered to me by mail. 
It costs me $5. The clinic, themselves would pick you up [at home] if need be to make 
your appointment.” (35 years, white, Texas) 
“There can be some kinda, like, counseling center, that at least someone can go to and 
talk about things like this, 'cause sometimes people just wanna talk. Or, I know there's 
numbers and things that people give us, but sometimes people wanna talk to someone 
face to face. Don't wanna be over the phone, they wanna actually speak to someone, uh, 
face to face like we get that emotion and that feel from someone else.”  
(23 years, black, Texas) 
 
Health Agency 
Agency was discussed in terms of caring for oneself, and in taking responsibility for one’s own 
healthcare. Participants often spoke about being strong and doing what needed to be done to 
access care and remain healthy. 
“I’m very anal about things. I have to have all of my paperwork. I have to have all 
materials ready. I have to have everything. I plan in advance everything…  I’m very like 
the person that’s always ready. They [clinic staff] were kind of surprised and they were 
glad that I was the kind of person that I am. Because they told me in this case that people 
have gone through like a duration period in their life where they’re just constantly 
wallowing on it and like dwelling on it… I’m very like “assess the problem and fix it” 
and like you know get keep going about my life.” (26 years, Latino, Texas) 
“I mean I can make up a bunch of excuses, to tell myself but, I mean, there were 
definitely opportunities when it could have happened, but I just chose to not go through 
with it just because I wasn’t ready to hear it myself if it were actually a positive result. At 
some point becomes like a personal responsibility thing as to whether or not you’re going 
to follow, you know, advice on what people say or do, whether or not you gonna engage 
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and stuff. For me, you know, it was I knew about it, I knew that it was a possibility and I 
just kind of didn’t care at the time.” (29 years, Latino, Florida) 
 
Participants also maintained that individuals had to find their own way to stay in care and that, 
ultimately, it was all about the individual’s mindset and own agency towards remaining healthy. 
According to participants, if the drive or motivation was not there, then it was foreseeable that 
individuals would neither seek help nor care for their overall health. These participants often 
expressed a strong sense of self-reliance. 
“It's because people have to take the initiative to wanna prevent things like this from 
happening… it's our responsibility to make sure that we're protecting ourselves like we 
need to. And if you don't take the initiative to do that, then there's really not much that 
you all can do. 'Cause once again, it takes two to tango. If you wanna protect yourself, 
you have to make sure that you're doin' that. You can't have somebody force you. So not, 
not necessarily much I don't think.” (23 years, black, Texas) 
 
PrEP as a Missed Prevention Opportunity 
  Many participants considered starting PrEP prior to their HIV diagnosis but missed the 
opportunity to start due to a variety of reasons. A few participants considered initiating 
conversations with their providers about PrEP and their concerns about potential symptoms but 
either waited too long or had issues scheduling these appointments. Others were unsure where to 
get PrEP or who they could speak to about it. Two participants initiated PrEP conversations with 
providers; one provider discouraged the participant from initiating, saying that PrEP was 
unreliable, and the other admitted they didn’t know enough about PrEP to prescribe it, which 
frustrated the participant. 
“I did think about getting it and you know, taking it as something that would be good for 
me. I was thinking about taking it, but like I said, I didn’t know where to even get it from. 
So I was not aware of you know where I would be able to get it, or how much it would be 
or anything like that.” (24 years, white, California) 
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“I checked it out a couple times out of curiosity online, and- and wasn't sure like, you 
know, it says how hard it is on your liver, or it was. I think it might have been improved 
by then. So, I just kind of weighed options, and stalled, and I feel like I waited too long, 
unfortunately, to get on that.” (47 years, white, Florida) 
“I did ask my doctor, my previous PCP, who had been my doctor for 15/16 years, I did 
ask him about going on PrEP. You know “hey I want to go on PrEP” and he gave me this 
deer in the headlights look like “what is that? I don’t know what that is.” And so like I 
explained to him. It’s truvada, it’s you know pre exposure prophylaxis, and he’s just like 
‘you would need to go, go to the downstairs where they have the communicable diseases 
department where they might know. And I was just like I was like aggghh.”  
(43 years, multiracial, Hawaii) 
 
DISCUSSION 
  Linking and retaining HIV-positive sexual minority men in primary care is critical from 
both a disease management and epidemiological perspective.8-10,13,19,41,42 Consistent engagement 
in HIV care plays a pivotal role in improving patient health outcomes as well as controlling 
incident cases by preventing onward HIV transmission by people with detectable viremia.43-45 
Despite a robust and multi-faceted national strategy to end the HIV epidemic, there continues to 
be fall-outs in care, especially among GBM of color.46 Our findings highlight avenues for 
improvement in HIV testing and PrEP uptake among HIV-negative men. Moreover, we 
identified factors that impede swift linkage to and adequate engagement in HIV care, including 
financial burden, competing priorities, and fear and stigma. Our findings also point to factors that 
facilitate linkage and engagement, such as financial assistance, positive patient-provider 
interactions, auxiliary support services, and individual health agency. 
  Participants identified HIV self-testing (HIVST) as a facilitator to testing, highlighting 
the ability to test comfortably in the privacy of their homes as an appealing incentive. Studies 
have shown that HIVST is a highly acceptable alternative to venue-based testing for GBM, 
facilitates more frequent testing, and could lead to higher risk reduction.47-50 This is a particularly 
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salient finding given the EtE push towards identifying individuals who are unaware of their HIV 
infection. In fact, widespread adoption and distribution of HIVST kits may increase testing rates 
among those who are not typically engaged by testing centers but suspect they may be HIV-
positive.51,52 
 Further, participants identified barriers and facilitators to successful engagement in HIV 
primary care that can guide best practices at not only the policy and organizational level but also 
at the individual levels. At the policy-level, men echoed the importance of sustaining health 
policies that help PLHIV cover medical costs and have been found to increase ART adherence as 
well as retention in care, such as the AIDS Drug Assistance Program (ADAP), the Ryan White 
Program, and housing support programs.27,53-56 These findings point towards the need to help 
HIV-positive clients have a stable environment where they can prioritize their own health. At the 
organizational level, participants emphasized how auxiliary support services, such as 
transportation coverage and mental health care, can make a difference in their retention in care. 
Similar findings have been found by Remien et al. in their 2015 qualitative study of PLHIV,57 
and by Rooks-Peck et al. in their 2018 meta-analysis study of mental health and retention in 
care.58  
  Participants also noted the desire to have medical providers who treated them with 
kindness and respect, listened to their concerns, were empathic to their diagnosis, and were 
communicative. Studies have shown that stigma within patient-provider relationships greatly 
contributes to the lack of trust that GBM have in the medical system; addressing this stigma can 
maximize patient retention and overall health.59-61 In fact, in their 2016 study on empathic 
communication, Flickinger et al. found that providers who actively exhibited empathy with their 
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patients promoted emotional connections and encouraged patients’ self-efficacy regarding 
medication adherence.62,63  
Moreover, Many participants noted being interested in PrEP prior to their HIV diagnosis 
but were not prescribed it in time. Some described not receiving necessary counsel from their 
primary care doctor, with one participant being discouraged against PrEP use, which represented 
an unfortunate missed prevention opportunity. These findings are similar to those documented in 
studies of provider-related barriers to PrEP access.64-67 These provider-related factors suggest 
that organizations could benefit from more concerted efforts to provide resources to and arrange 
yearly capacity building for their providers to maximize skills surrounding communication, 
sexual history taking, and prescribing PrEP.68,69  
Health agency, defined as an individual’s inner capacity to overcome obstacles related to 
their illness, was prevalent in our findings.70-73 At the individual level, men reiterated the need to 
find inner strength to take charge of their own health care. Many participants spoke about their 
care in terms of taking responsibility. They emphasized the need for an inner drive or mentality 
to remain healthy as a facilitator to accessing care. The research on health agency applied to HIV 
care is scant, making this finding particularly innovative. In their 2015 observational study of 
patient agency in healthcare settings, Hunter et al. described how patients often struggled to 
become knowledgeable about their condition and could fail at managing it; as such, the authors 
denoted health education as a way to enhance patient agency.70-73 Interestingly, in describing the 
sense of responsibility they felt towards their own health, participants in the present study often 
alluded to becoming more educated about HIV as a means to engaging in care. Many 
underscored needing to understand “it was not a death sentence” or that they “can lead normal 
healthy lives.” These findings suggest that engaging in patient education, either through clinic or 
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other behavioral interventions, may significantly impact patients’ engagement in care. Despite 
this individualistic approach, many participants simultaneously cited feeling a need to connect 
with other individuals who shared their experiences as a way of coping with HIV and 
maintaining themselves in care. In fact, many reported receiving instrumental and emotional 
support from friends and family when looking to confirm their HIV diagnosis. Establishing a 
good support system has been documented in several studies as a buffer for negative health 
consequences and contributes to improved medication adherence and overall care.27-29 
Limitations 
These findings helped generate insights, themes, and nuances regarding GBM’s 
experiences accessing health care. However, these findings are not generalizable to the general 
GBM population in the US. Our recruitment strategy explicitly emphasized “free at-home HIV 
testing” as well as compensation for completing study assessments. Those with more severe HIV 
testing anxiety and those who may be unknowingly living with HIV may not have enrolled in our 
cohort. Nonetheless, our qualitative findings did highlight some HIV-related anxiety among 
participants. Further, we only interviewed participants to whom we could successfully deliver an 
HIV test result over the phone; as such, their experiences may differ from those who tested HIV-
positive but avoided our delivery efforts. In addition, our recruitment strategies led us to 
interview individuals who were more likely to be engaged in HIV care. Despite many themes 
being salient across our sample, our study would have benefitted from the perspectives of 
individuals who were not engaged in care. Further, we cannot rule out that social desirability bias 
may have influenced study findings, as participants may have softened or minimized negative 
experiences in care. Finally, these qualitative data are useful for generating theories and 
hypotheses but by no means signify any causal inferences.  
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Conclusions 
  As health officials seek strategies to curb the epidemic, they must pay close attention to 
engaging PLHIV in primary care. By individualizing care to meet the needs of GBM, the public 
health sector comes much closer to achieving sustainable, undetectable community viral loads. 
Furthermore, by addressing the root causes behind an individual’s reasons for forestalling or 
disengaging from care, such as homelessness, poverty, and racial/ethnic disparities, we can move 
closer to reaching the UNAIDS 90-90-90 targets. Notably, half of our sample identified as 
people of color. Therefore, the present findings signify perspectives from individuals who are 
most disenfranchised in the HIV epidemic. Particularly, this vulnerable sector needs support at 
the individual, organizational, and policy level to overcome the obstacles that hinder their 
navigation of the healthcare system. Finally, the healthcare system must provide more resources 
to increase staff capacity building to combat the unique challenges faced by this population.  
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Table 4.1. Socio-demographic characteristics, HIV-positive GBM, n = 50 
Characteristic M SD 
Age 31.70 8.10 
    Frequency % 
Race/Ethnicity     
  White 24 48 
  Black 8 16 
  Latino 14 28 
  Multiracial 4 8 
Sexual Orientation     
  Gay, Queer, Homosexual 47 94 
  Bisexual 3 6 
Education     
  < High school diploma 2 4 
  High school diploma or GED 5 10 
  Some college or technical school training 29 58 
  College graduate + 14 28 
Employment Status     
  Full-time (40 hours per week) 27 54 
  Part-time (less than 40 hours per week) 7 14 
  Working- or full-time student 9 18 
  Unemployed/Other 7 14 
Annual Income     
  Less than $20,000 22 44 
  $20,000-$49,999 20 40 
  $50,000+ 8 16 
Has a main partner     
  Yes 18 36 
  No 32 64 
Health Insurance     
  Yes 27 54 
  No/do not know 23 46 
Has a Primary Care Provider     
  Yes 26 52 
  No/do not know 24 48 
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Engaged in sex work (past 12 months)     
  Yes 16 32 
  No 34 68 
Housing Instability in past 5 years     
  Yes 20 40 
  No 30 60 
Self-reported HIV Status at Baseline     
  HIV-negative 14 28 
  I don't know; I am unsure 36 72 
Have you ever been tested for HIV?     
  In the past 12 months 17 34 
  More than a year ago 26 52 
  Never 7 14 
Prior PrEP use     
  Yes 2 4 
  No 48 92 
Diagnosed with an STD in the last 12 Months     
  Yes 10 20 
  No 40 80 
Region     
  Northeast 7 14 
  South 31 62 
  Midwest 3 6 
  West 9 18 




CHAPTER 5: CONCLUSION  
OVERVIEW 
  This dissertation used a multi-method approach to understand how individual-, 
contextual- and structural-factors influence HIV risk in an U.S. national sample of GBM and 
engagement in HIV care among those newly diagnosed with HIV. First, using the syndemic 
theory framework, we assessed the prevalence of eight syndemic conditions and explored their 
associations with a composite measure of HIV risk (Aim 1). Second, using a resilience 
framework, we described the socio-demographic and geographical differences in resilience, and 
explored whether resilience was associated to a composite measure of HIV risk and to individual 
sexual risk behaviors (Aim 2). Finally, using the socio-ecological model, we explored linkage 
and engagement in care for HIV+ GBM and identified multi-level barriers and facilitators to 
engagement in care (Aim 3). This dissertation used data collected as part of the Together 5,000 
study, a U.S. national, internet-based cohort study of men, transgender men, and transgender 
women who have sex with men. For Aims 1 and 2, we conducted secondary analysis of 
quantitative survey data from a cohort of 6,118 GBM ages 16-49 at high risk for HIV 
transmission.1,2 Further, the outcome of interest for Aims 1 and 2 was a compositve measure of 
HIV risk. We assessed the relationship between individual and cumulative syndemics, resilience 
and HIV risk using adjusted multiple linear regressions. For Aim 3, we conducted secondary 
analysis of qualitative data from 50 GBM diagnosed HIV-positive during their participation in 
Together 5,000 using thematic analysis to identify barriers and facilitators to engagement in care. 
This dissertation set out to re-conceptualize the application of Syndemic Theory by incorporating 
a unique set of social condition variables, such as incarceration and homelessness history, often 
left out in traditional syndemic analyses.3-6 This dissertation also explored both deficit- and 
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strength-based approaches to HIV prevention through a syndemic framework and a resilience 
framework.7 Further, the qualitative data from recently diagnosed individual’s experience 
accessing HIV care provides valuable insights into barriers and facilitators to engagement in care 
across the U.S. As such, this research provides new information on the state of the HIV policies 
and hard to reach populations in the US and contribute toward the goal of ending AIDS in the US 
by 2030.8 
SUMMARY OF FINDINGS 
Aim 1: Syndemics and HIV Risk 
Aim 1 extended the recent work on syndemics by exploring the association between eight 
syndemic conditions (intimate partner violence, depression, anxiety, childhood sexual abuse, 
polydrug use, hazard alcohol use, incarceration history and homelessness) and HIV risk before 
and after controlling for selected socio-demographic characteristics. In estimating the prevalence 
of syndemics among our participants (n = 6,118), half (50.4%) reported previous intimate partner 
violence (IPV), roughly one-quarter reported symptoms of anxiety (30.6%), depression (28.8%), 
and childhood sexual abuse (CSA, 24.3%), one-fifth (20.3%) reported unstable housing within 
the last 5 years, and 14.5% reported having been incarcerated at least once in their lives. 
Moreover, 21.2 % and 11.9% reported hazard alcohol and polydrug use, respectively. One-
quarter (24.7%) of participants reported one syndemic condition, 20.3% reported two co-
occurring syndemics, 15.8% reported three, 10.3% reported four, and 8.8% reported more than 
four co-occurring syndemics. In adjusted multiple linear regressions, IPV, childhood sexual 
abuse, polydrug use, incarceration history and homelessness were positively associated with HIV 
risk. We also found that increasing cumulative syndemic burden was associated with higher HIV 
risk. Those who reported 3 or more co-occurring conditions had the highest risk for HIV. These 
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findings highlight the need for public health practitioners to recognize housing instability and 
incarceration as important social determinants of health and as catalysts for worsening health 
outcomes.9-11 Further, these findings shed light on the socioeconomic vulnerabilities impacting 
GBM across the U.S., particularly among racial/ethnic minorities and, as such, future studies 
should further explore the impact of additional structural factors, including racial and ethnic 
discrimination on HIV prevention and care. 
Aim 2: Resilience and HIV Risk 
  In Aim 2, we employed a strength-based approach to HIV prevention by describing the 
levels of resilience in our sample of GBM. We examined the socio-demographic differences in 
resilience and assessed the relationship between resilience and HIV risk. We found higher mean 
resilience scores among those identifying as black, with higher education, having full-time 
employment, higher incomes, and those who have health insurance. There was a lower mean 
resilience among those engaging in transactional sex in the last 12 months and among those 
having been diagnosed with an STD in the last 12 months.  
We ran three multiple linear regression models between resilience and HIV Risk; Model 
1 using the composite MSM risk Index measure, Model 2 using only a measure of condomless 
receptive anal sex, and Model 3 using a measure of condomless insertive anal sex. After 
adjusting for psychosocial and demographic characteristics, we found no statistically significant 
association between resilience and our composite measure of HIV risk and condomless insertive 
anal sex. However, we found a significant association between higher resilience and lower 
condomless receptive anal sex acts in the last 3 months. Unfortunately, we may have been 
limited in its ability to fully measure resilience and could have accounted for our non-significant 
findings. Our measure of resilience only measures adaptability and coping, and although this is 
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an acceptable construct to measure, resilience may be better conceptualized as a multi-
dimensional factor. It may also be more appropriate to measure the association between 
resilience and HIV risk by focusing on specific sexual behaviors rather than a composite measure 
of sexual risk. Our findings highlight gaps and the need to promote health-enhancing positive 
factors in HIV intervention work. 
Aim 3: Engagement in Care among newly diagnosed HIV-positive GBM 
  In Aim 3, we explored linkage, engagement and retention in HIV care through secondary 
analysis of in-depth interviews with 50 GBM 3-months after delivery of their preliminary HIV-
positive test results. Particular attention was given to the challenges participants faced with their 
linkage-to-care and initiation of ART. Almost half (46%) were uninsured and did not have a 
primary care provider (48%). The majority (94%) of participants reported being linked-to-care 
and had their diagnosis confirmed with a healthcare provider, while only 74.5% of those reported 
initiating ART.  
  We explored the barriers and facilitators to engagement in care using the socioecological 
framework. Through thematic analyses, we identified four major themes related to participants’ 
engagement in care: 1) Reasons for HIV testing (e.g., HIV self-testing and expectation of 
positivity), 2) Linkage-to-care (e.g., appointment/logistic issues and social support as 
encouragement), 3) Barriers (e.g., financial burden, competing priorities and fear/stigma) and 
facilitators (e.g., financial assistance, patient-provider relationships, auxiliary support services 
and health agency) to engagement in HIV care, and 4) PrEP as a missed prevention opportunity. 
These results suggest that addressing policy-, social- and individual-level barriers could improve 
GBM’s engagement in HIV care. Further, capitalizing on GBM’s health agency through 
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partnerships with local agencies and fostering better patient-provider relationships could 
optimize continuity of HIV care.12-15 
 
POLICY IMPLICATIONS  
  Overall, the findings from this multi-method dissertation suggest that the HIV epidemic 
is complex and, therefore, an effective prevention and intervention national agenda requires an 
understanding of the diversity and dynamic nature of individuals, communities, and our socio-
political environment. Firstly, our efforts to address HIV disparities will not be successful 
without careful consideration of the structural and social determinants of health. Housing is an 
unique social determinant of health that has a significant influence on individual’s lives.16,17 It is 
also an indicator of broader structural processes of inequality that fuel HIV vulnerability and 
sustain poor health outcomes.16-20 Particularly, housing is linked to a myriad of economic and 
social factors. Research has found that a lack of stable and secure housing has a direct negative 
effect on physical and psychological well-being, socioeconomic attainment, sexual behaviors, 
and recidivism.16,17,21-23 Our findings demonstrate that environmental and behavioral factors such 
as homelessness, incarceration are prevalent among GBM in the U.S. In fact, we found that 
unstable housing not only contributes to HIV risk but was also a barrier to engagement in care. 
Past research has established that unstable housing can have a detrimental effect on the HIV 
continuum of care by delaying linkage to care, increasing the likelihood of discontinuity in care, 
and decreasing the likelihood of viral suppression.  
 Health policies that target these structural and social determinants to HIV infection can 
have a significant impact on the epidemic, particularly those that expand access to prevention 
services and treatment.13,24,25 The 2019 Ending the HIV Epidemic in America initiative aims to 
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reduce all new HIV infections by 90% in the next 10 years.24 As such, there may be political 
clout to advocate for evidence-based policies that offer assistance to PLWHIV and eliminate the 
economical burdens associated to HIV testing and other biomedical interventions. In the last 
decade, there has been considerable improvement in expanding Medicaid, ADAP eligibility and 
housing for PLWHIV; however, there is immense eligibility variation between states.26-30 Given 
this, there needs to be a push towards standardizing eligibility across states in order to reduce 
HIV infections across the nation. Some states (e.g., California and New York) have produced 
policies (e.g., HIV/AIDS Services Administration) or consistently fund programs (e.g., Housing 
Works) that have made positive impacts on sexual minority individuals.31,32 Whereas, states like 
Texas and Florida, who did not expand access to Medicaid, have some of the most restrictive 
eligibility criteria for ADAP, and as a result PLHIV in those states face several barriers to care 
which inhibits their ability to achieve viral suppression and stop the spread of the virus.27,29,33  
  The shift to a biomedical paradigm of prevention has led to less consideration of 
individual-level interventions. A resurgence of behavioral interventions that address intra- and 
inter-personal factors, that promote agency and resilience, and increases health education may be 
necessary to end the epidemic. Our findings suggest that agency and resilience can have an 
impact on how GBM understand, seek and interact with HIV prevention tools. Evidence-based 
behavioral interventions, such as the CDC’s Many Men, Many Voices (3MV), have begun to 
incorporate resilience building exercises given their understanding that resilience can be learned, 
developed and influence success in changing behaviors.34 Additionally, incorporating 
motivational interviewing into field outreach and behavioral interventions can also increase the 
likelihood of HIV counseling, health education, HIV testing, and, ultimately, improve HIV 
prevention and care outcomes.35,36  
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  Stigma, racism, and marginalization have been identified as drivers of the epidemic. 
Studies have found that discrimination is often compounded with other sources of stigma, 
including stigma around gender identity and racism.15,37-45 Gender roles have been shown to 
influence the perception that one male partner is “womanly” or “weak”, which in turn facilitates 
problematic power dynamics, such as when the more ”manly” partner exerts undue influence 
over decisions surrounding condom use.37,38,45,46 This stigma produces marginalization in MSM 
and, in turn, strongly influences an individual’s vulnerability for HIV infection through 
engagement in higher risk sexual behaviors.38,40,41,46-48 This is particularly true for individuals in 
disadvantaged social positions, who likely to go through psychologically straining life 
experiences (stressors) due to their intersecting identities (e.g., being gay and black).38,40,49-51 
Therefore, interventions that address the management of stigma, enhance social support and 
health agency continue to be necessary.52    
 
FUTURE DIRECTIONS 
  This research identified multi-level factors that are associated with HIV risk and 
engagement in care. Firstly, although our expanded syndemic model offers a more 
comprehensive understanding of the unique HIV risks for GBM, more research is needed. The 
way in which we conceptualized our syndemic variables simplifies a large issue into a binary 
variable. As such, more complex mathematical modelling may be needed to fully understand 
how syndemics, including housing and incarceration, impact risk. Secondly, while we did not 
find that resilience was associated to our composite measure of HIV risk, we found a significant 
association to condomless receptive anal sex. The conceptualization of resilience as a 
unidimensional construct may be inadequate for this population. Given this, we believe our study 
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was limited in its ability to fully measure resilience. The Connor-Davidson Resilience scale only 
measures adaptability and coping, and although this is an acceptable construct to measure, 
resilience may be better conceptualized as a multi-dimensional factor, vis-à-vis syndemics. 
Future research may benefit from assessing HIV risk through the presence of resilience-
promoting (e.g., social support, hardiness and coping, etc.) or resilience-diminishing (e.g., 
internalized homophobia) factors. As such, a more nuanced measurement of resilience and 
expanded research on the ways it impacts HIV prevention and care is needed. Finally, more 
research is needed on the role of health agency on GBM’s engagement in care. The research on 
health agency applied to HIV care is scant, making our findings particularly innovative. Given 
that health agency was a salient theme in our qualitative data, we believe that empirical research 
should be conducted to quantify and explore its association to HIV care outcomes (e.g., retention 
in care, viral suppression, etc.). 
 
LIMITATIONS 
  Our findings should be interpreted through careful consideration of its limitations. In 
Aims 1 and 2, we used cross-sectional internet surveys from 6,118 from across the U.S. The 
cross-sectional design of this study prevents making any conclusive causal claims about the 
temporality and directionality of the relationships we observed for Aims 1 and 2. This study was 
not designed to prove causation, only to correlate, and therefore causal inferences should be 
interpreted with caution.53 Although this fully online study allowed for increased geographical 
reach, it also increased the potential for fraudulent participants.54,55 Further, this study relied 
exclusively on data from self-reported surveys and, while measures to increase the validity of the 
data were put into place, social desirability and recall bias may have affected the study 
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findings.56 Further, the study population was recruited via sexual networking apps and 
represented a sample of those at highest risk for HIV, who are not on PrEP at enrollment. Given 
the non-probability sampling, we are unable to generalize the Aim 1 and 2 results to other GBM. 
Our findings are limited to a sample of HIV-negative cis-gender GBM and we cannot rule out 
that there may be unique differences in syndemic prevalence and resilience profiles for 
individuals who are gender non-conforming and those who are HIV-positive.  
Finally, our Aim 3 qualitative findings helped generate insights, themes, and nuances 
regarding GBM’s experiences accessing health care. However, these findings are not 
generalizable to the general GBM population in the U.S. Our recruitment strategy explicitly 
emphasized “free at-home HIV testing” as well as compensation for completing study 
assessments. Those with more severe HIV testing anxiety and those who may be unknowingly 
living with HIV may not have enrolled in our cohort. Nonetheless, our qualitative findings did 
highlight some HIV-related anxiety among participants. Further, we only interviewed 
participants to whom we could successfully deliver an HIV test result over the phone; as such, 
their experiences may differ from those who tested HIV-positive but avoided our delivery 
efforts. In addition, our recruitment strategies led us to interview individuals who were more 
likely to be engaged in HIV care. Despite many themes being salient across our sample, our 
study would have benefitted from the perspectives of individuals who were not engaged in care.  
 
CONCLUSIONS 
  Overall, the findings from this multi-method dissertation suggest that the HIV epidemic 
is complex, and therefore an effective response requires an understanding of the diversity and 
dynamic nature of individuals, communities, and our socio-political environment. We 
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demonstrated that environmental and behavioral factors such as homelessness, incarceration are 
prevalent among GBM in the U.S. and contribute to HIV acquisition, thus offering compelling 
evidence for the adoption of these variables in future syndemic models. Further, there needs to 
be a more comprehensive investigation of the unique risk factors in this population, particularly 
those that may impact uptake and adoption of preventive HIV health behaviors, such as pre-
exposure prophylaxis (PrEP). For instance, larger structural factors like societal racial 
discrimination, anti-immigration laws, lack of health insurance coverage and unemployment can 
significantly impact adherence to biomedical tools and use of testing services. Future research 
should explore these social and structural determinants within the context of HIV prevention. 
There is a need for targeted interventions for those at the highest risk, particularly racial and 
ethnic minorities and those from impoverished communities to increase HIV testing frequency 
and facilitate better engagement in care.  
  As seen in our study findings, HIV prevention is a multi-faceted process. There is a need 
for a more holistic approach to prevention, wherein HIV prevention is conceptualized as more 
than just HIV testing and PrEP initiation but that takes into account intrapersonal (e.g,, 
resilience) and interpersonal factors (e.g., social support). Finally, addressing policy-, social- and 
individual-level barriers could improve GBM’s engagement in HIV care. Capitalizing on GBM’s 
health agency through partnerships with local agencies and fostering better patient-provider 
relationships could optimize continuity of HIV care. We possess the tools needed to end the HIV 
epidemic in the U.S., particularly by advocating for a new federal policy which streamlines HIV 
testing, linkage-to-care and ART initiation.  
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APPENDIX A: ENROLLMENT SURVEY 
Take care of yourself, take care of your community. 
  
Join Together 5000, a new LGBT-led university research study. 
  
Earn up to $200 by taking surveys online and testing yourself with free at-home HIV test 
kits. 
 
Earn $15 or more per survey, get free at-home HIV test kits, and earn at least $15 for getting 
tested. Full participation adds up to $200!  
 
 




Age. How old are you? 
A. Number entry 
 
[IF Age ≤ 15, SKIP TO INELIGIBLE FULL STOP, IF > 49 ALLOW TO FINISH 
SURVEY BUT END ON INELIGIBLE ASK FOR CONTACT FOR FUTURE 
RESEARCH] 
[IF Age < 18, DISPLAY CONSENT1, CONSENT2, CONSENT3] 
 
Consent1. What is this study focused on? 
A. Sexuality, sexual health, and substance use 
B. Eating habits 
C. Sleeping patterns 
 
 
Consent2. Which of these is a risk of the study? 
A. Side effects from a treatment being used 
B. Exercise related fatigue 
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C. Discomfort answering personal questions 
 
Consent3. How long is this survey expected to take? 
A. 5 minutes 
B. 20-30 minutes 
C. 60 minutes 
 




Race. Which racial or ethnic group do you belong to? (Please select all that apply)  
A. American Indian or Alaska Native 
B. Asian 
C. Black/African American 
D. Native Hawaiian or Other Pacific Islander 
E. White 
F. Other (Please specify): ___________________ 
 
Employ. Which of the following best describes your current employment status? 
A. Full-time (40 hours per week) 
B. Part-time (less than 40 hours per week) 
C. Part-time work - full time student 
D. Permanent or temporary disabled and NOT working 
E. Permanent or temporary disabled BUT working “off the books” (or "under the table")  
F. Unemployed -- Student 
G. Unemployed – Other 
 
Educ. What's the highest level of education that you have completed? 
A. 8th Grade or less 
B. 9th Grade 
C. 10th Grade 
D. 11th Grade 
E. High School Diploma or GED 
F. Some College or Associates Degree 
G. Currently enrolled in college 
H. 4-Year College Degree (BA, BS, BFA) 
I. Some Graduate School 
J. Master's Degree 
K. Doctorate Degree 
 





[IF USAYN = B INELIGIBLE, ALLOW TO FINISH SURVEY BUT END ON 
INELIGIBLE ASK FOR CONTACT FOR FUTURE RESEARCH] 
 
Zipcode. What is the Zip code of your home address? 
A. [5 digits] __________ 
 
HIVStatus. What is your HIV status? 
A. HIV-negative 
B. HIV-positive 
C. I don’t know; I am unsure 
 
[IF HIVStatus = B, INELIGIBLE, ALLOW TO FINISH SURVEY BUT END ON 
INELIGIBLE ASK FOR CONTACT FOR FUTURE RESEARCH, ASK Diagnosis, 
THEN CONTINUE TO Sex] 
 
Diagnosis. What year were you diagnosed with HIV? 
A. [validated number entry] 
 
[IF Diagnosis = 2017, ASK LastNegTes] 
 
LastNegTest. When was the last time you received an HIV-negative test prior to being 
diagnosed HIV-positive?  
A. I had never been tested for HIV before my diagnosis 
B. I last tested negative more than 5 years ago 
C. I last tested negative between 2 and 5 years ago 
D. I last tested negative between 1 and 2 years ago 
E. I last tested negative 6 to 12 months ago 
F. I last tested negative 3 to 6 months ago 
G. I last tested negative within the past 3 months  
 
[IF HIVStatus = A OR C, ASK LastHIVtest] 
 
 
LastHIVtest. When was your last HIV Test? 
A. Within the last month 
B. 1-3 months ago 
C. 3-6 months ago 
D. 7-12 months ago 
E. [Baseline only] 1 to 2 years ago 
F. [Baseline only] More than 2 years ago 
G. [Baseline only] I’ve never been tested 
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[IF LastHIVtest = A, B, C, D, E, ASK TestFreq] 
TestFreq. How often do you typically get tested for HIV? 
A. Less than once a year 
B. Once a year 
C. Twice a year 
D. Three times a year 
E. Four times a year 
F. Five times a year 
G. Six times a year 
H. Seven or more times a year 
  
[IF HIVStatus = A or C, ASK PrEPstatus, PrEPnetwork, NonPrescPrEP, PEPstatus, 
THEN CONTINUE TO Sex] 
 
PrEPstatus. Have you ever been prescribed HIV medications (e.g., Truvada) for use as PrEP 
(Pre-Exposure Prophalyxis)? 
A. I don’t know what PrEP is 
B. No, never taken PrEP 
C. Yes, I am currently on PrEP 
D. Yes, but I am not currently taking PrEP 
 
[IF PrEPstatus = D, ask PrEPdisruption] 
 
[IF PrEPstatus = C, INELIGIBLE, ALLOW TO FINISH SURVEY BUT END ON 
INELIGIBLE ASK FOR CONTACT FOR FUTURE RESEARCH] 
 
PrEPdisruption. Why did you stop taking PrEP? [Write in] _________ 
 
[DISPLAY PrEPnetwork AND NonPrescPrEP IF PrEPstatus = B, C, or D] 









NonPrescPrEP. Have you ever taken HIV medications to prevent HIV, without a 
prescription (e.g., been given PrEP from a friend/partner)? Check all that apply. 
A. Yes, after an exposure/risk 




PEPstatus. Have you ever been prescribed HIV medications AFTER an exposure to prevent 
getting HIV (for example, sex without a condom or the condom broke). This is called Post 
Exposure Prophylaxis, PEP. 
A. No, never 
B. Yes, in the last year 
C. Yes, more than one year ago 
 
ClinicTrial. Are you currently participating in an HIV vaccine or HIV drug prevention 




[IF ClinicTrial = A, INELIGIBLE, ALLOW TO FINISH SURVEY BUT END ON 
INELIGIBLE ASK FOR CONTACT FOR FUTURE RESEARCH] 
 




Gender. What gender do you currently identify as? 
A. Male 
B. Female 
C. Transgender female 
D. Transgender male 
E. Something else (Please specify): _____ 
 
[IF Sex = B AND Gender = B (i.e. cisfemales) INELIGIBLE, ALLOW TO FINISH 
SURVEY BUT END ON INELIGIBLE ASK FOR CONTACT FOR FUTURE 
RESEARCH] 
 
SexOrientation. Which best describes how you identify your sexual orientation? 
A. Gay, Queer, Homosexual 
B. Bisexual 
C. Straight, Heterosexual 
D. Other (Please specify): ________ 
 
CDC MSM Risk Index 
 
 
MalePartners. In the last 3 months, how many men have you had anal sex with? 
A. 0-90+ 
  





[DISPLAY UAVIFemale IF FemalePartners > 0] 
 
UAVIFemale. How many times have you had anal/vaginal sex without a condom with a 
female partner in the last 3 months? 
A. 0-90+ drop down 
 
TransmenPartners. In the last 3 months, how many transmen (female-to-male, FTM) have 
you had anal/vaginal sex with? 
A. 0-90+ 
 
TranswomenPartners. In the last 3 months, how many transwomen have you had 
anal/vaginal sex with? 
A. 0-90+ 
 
URAI. In the last 3 months, how many times did you have receptive anal sex (you were the 








[DISPLAY URAIPos if URAI and PozMalePartners ARE NOT 0] 
URAIPos. In the last 3 months, how many times did you have receptive anal sex (you were 
the bottom) with a man without a condom with a man who was HIV-positive? 
A. 0-90+ 
 
UIAI. In the last 3 months, how many times did you have insertive anal sex (you were the 
top) without a condom with a man? 
A. 0-90+ 
 
UIAIPos. In the last 3 months, how many times did you have insertive anal sex (you were the 





The following is a list of sexually transmitted infections. For each infection, please indicate 
when you were diagnosed.  
 
 How long ago was this? 




1-5 Years More than 
5 years 
STD1. Rectal/Anal Gonorrhea or 
Chlamydia 
    
STD2. Oral/Pharyngeal Gonorrhea or 
Chlamydia 
    
STD3. Genital warts, anal warts, HPV     
STD4. Herpes, HSV1, HSV2     
STD5. Syphilis     
STD6. Hepatitis C     
STD7. Hepatitis B     
STD8. Urethritis     
 
 
MainPartner. Are you currently in a relationship with someone to whom you feel committed 




Polyamorous. Are you currently in a polyamorous relationship (a committed relationship 




[IF MainPartner = A, ASK UAVIMain THROUGH PartnerGender, OTHERWISE 
SKIP TO Druguse] 
 
UAVIMain. How many times have you had anal/vaginal sex without a condom with your 
main partner in the last 90 days (since date)? 
A. 0-90+ 
 
PartnerAge. What is your main partner’s age? _______ 
 
PartnerStatus. What is your main partner’s HIV status?  
 
A. My partner told me he/she is HIV-positive 
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B. I think my partner is HIV-positive 
C. I don’t know my partner’s HIV status 
D. I think my partner is HIV-negative 
E. My partner told me he/she is HIV-negative 
 
[IF PartnerStatus = A, B, ASK PartnerVL, THEN CONTINUE TO PartnerGender] 
 
PartnerVL. Is your main partner’s HIV viral load undetectable? 
A. Yes 
B. No 
C. I don’t know 
 
[IF PartnerStatus = D, E, ASK PartnerPrEP, THEN CONTINUE TO PartnerGender] 
 
PartnerPrEP. Is your main partner on pre-exposure prophylaxis (PrEP)? 
A. Yes 
B. No 
C. I don’t know 
 
PartnerGender. What is your partner’s gender identity? 
A. Female 
B. Male 
C. Transgender male 
D. Transgender female 
 
DrugUse. Which of the following drugs have you used in the past 90 days (since 




D. Crystal methamphetamine (meth, crystal, tina) 
E. Heroin 
F. MDMA, Ecstasy, Molly 
G. Ketamine (K) 
H. GHB 
I. Prescription pain killers (for fun, to get high) 
J. Other Prescription drugs (for fun, to get high) 
K. Poppers 
L. LSD/Mushrooms/PCP 
M. Other (specify) 
N. None of the above 
 
Needles. Have you shared needles to inject drugs (e.g. heroin, steroids, crystal)? 
A. No, never 
B. Yes, in the last 12 months 
C. Yes, more than one year ago 
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AlcoholUse. In the past 3 months, how many days would you say you drank 5 or more 
alcoholic drinks in one sitting? 
A. 0-90 
 
CigaretteUse. How often to do you smoke cigarettes? 
A. Never 
B. A few times a year 
C. At least once per month 
D. 2-3 days per month 
E. 1-2 days per week 
F. Almost every day or every day 
 
Housing. What is your current living situation? (Check all that apply) 
A. Alone 
B. With Roommates 
C. With Family 
D. With Partner (spouse, boyfriend, girlfriend) 




Income. Which best describes your total yearly income during the last year? 
A. Less than $10,000 
B. $10,000 to $19,999 
C. $20,000 to $29,999 
D. $30,000 to $39,999 
E. $40,000 to $49,999 
F. $50,000 to $74,999 
G. $75,000 to $99,999 
H. $100,000 to $149,999 
I. $150,000 to $199,999  
J. $200,000 to $249,999 
K. $250,000 or more 
 
 
HousingInstability. Has there been a period of time in your life where you were unstably 
housed (e.g., couchsurfing, homeless)? 
A. No 
B. Yes, within the last 5 years 
C. Yes, but more than 5 years ago 
 
SexWork3M. In the last 3 months, were you given anything (money, drugs, a place to stay, 





DigitalCam. Do you have a digital camera (e.g., a phone with a camera or a device capable 
of taking digital photos)? 
A. Yes 
B. No 
C. I don’t know 
 
[IF DigitalCam = B or C, INELIGIBLE, ALLOW TO FINISH SURVEY BUT END ON 
INELIGIBLE ASK FOR CONTACT FOR FUTURE RESEARCH] 
 
 
HIVMail. Would you be willing to have an HIV test kit (in a plain unmarked envelope) 




C. I don’t know 
 




MailAlt. If you are unable to receive mail at your home, what if the package was sent to an 
alternative address (e.g. a friend, relative, workplace) for you to pick up there? 
A. Yes, I would be able to pick it up 
B. No, I would not be able to pick it up 
 
MailContact. If you can’t receive mail at home, and don’t have an alternative address, it will 
be difficult for us to get you the home HIV testing kit, and for you to participate. If you 
would still like to participate, we can contact you to try to arrange a way for you to get your 
testing kit. 
A. Yes, please contact me 
B. No, I am not able to receive an HIV home testing kit 
 
 
Recontact. As part of this study, we will want to reach out to you periodically. Would you be 







APPENDIX B: SECONDARY SURVEY 
INTRODUCTION SCREEN 
 
Welcome back!  
We look forward to having you as a participant in Together 5,000. Today we will ask you to 
complete an online survey that will take you about 20-30 minutes. For completing this 
survey, we will send you a $15 gift certificate. You can take breaks from the survey at any 
time. If you click the link we emailed you, it will take you right back to where you left off.  If 





BirthMonth. In what month were you born? 
A. Drop down list of months 
 
BirthYear. In what year were you born? 
B. Number entry with validation between 1900 and 2017 
 






F. Not applicable to me 
 
SexWorkYear. Have you exchanged money for sex in the past 12 months? 
A. No 
B. Yes, I’ve been paid for sex 
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C. Yes, I have paid for sex 
D. Yes, I’ve both been paid and have paid for sex 
 




[DISPLAY YearOut AND RecIncar IF Incarcerated = A] 
 
YearOut. In what year were you released from incarceration? 
A. (Drop down year list) 
 









OtherStudy. Are you currently participating in another HIV research study (e.g. Unite, 
Keeping it Lite, or Lite)? 
A. No 
B. Yes - Unite 
C. Yes – Keeping it Lite 
D. Yes – Lite 
E. Yes, some other study 
 
FirstOral. How old were you when you first had consensual oral sex with a male? 
A. Text entry validated to at or below current age 
 
FirstAnal. How old were you when you first had consensual anal sex with a male? 
A. Drop down 0 to 90+ 
 
 
Connor-Davidson Resilience Scale (10 – item) 
 

















Resilience1. I am able to adapt to change 0 1 2 3 4 
Resilience2. I can deal with whatever 
comes 
0 1 2 3 4 
Resilience3. I see the humorous side of 
things 
0 1 2 3 4 
Resilience4. Coping with stress 
strengthens me. 
0 1 2 3 4 
Resilience5. I tend to bounce back after 
illness or hardship. 
0 1 2 3 4 
Resilience6. I can achieve my goals 0 1 2 3 4 
Resilience7. Under pressure, I focus and 
think clearly 
0 1 2 3 4 
Resilience8. I am not easily discouraged 
by failure 
0 1 2 3 4 
Resilience9. I think of myself as a strong 
person 
0 1 2 3 4 
Resilience10. I can handle unpleasant 
feelings 





Multidimensional Peer-Victimization Scale – Current Student 
How often during the last school year has another student done these things to you?  
How often during the last school year has another 





PVSCurrent1. Punched me    
PVSCurrent2. Tried to get me into trouble with 
my friends 
   
PVSCurrent3. Called me names    
PVSCurrent4. Kicked me    
PVSCurrent5. Tried to make my friends turn 
against me 
   
PVSCurrent6. Made fun of me because of my 
appearance 
   
PVSCurrent7. Hurt me physically in some way    
PVSCurrent8. Refused to talk to me    
PVSCurrent9. Made fun of me for some reason    
PVSCurrent10. Beat me up    
PVSCurrent11. Made other people not talk to me    
PVSCurrent12. Swore at me    
     
MissSchool. How often did you miss school in the last year? 
A. Not at all 
B. Once 
C. More than once 
 
VictOnline. How often did these things happen online? 
A. Not at all 
B. Once 
C. More than once 
 
 
Multidimensional Peer-Victimization Scale – Former Student 
Think back to when you were in high school. How 





PVS1. Punched me    
PVS2. Tried to get me into trouble with my friends    
PVS3. Called me names    
PVS4. Kicked me    
PVS5. Tried to make my friends turn against me    
PVS6. Made fun of me because of my appearance    
PVS7. Hurt me physically in some way    
PVS8. Refused to talk to me    
PVS9. Made fun of me for some reason    
PVS10. Beat me up    
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PVS11. Made other people not talk to me    
PVS12. Swore at me    
 
MissSchoolRetro. How often did you miss school in the last year that you were in school? 
D. Not at all 
E. Once 
F. More than once 
 
VictOnlineRetro. How often did these things happen online when you were in high school? 
D. Not at all 
E. Once 








In your life, which of the following substances have you ever used?  For prescription 
medications, please report nonmedical use only. 
 Yes No 
ASSIST1a. Cannabis (marijuana, pot, grass, hash, etc.)   
ASSIST1b. Cocaine (coke, crack, etc.)   
ASSIST1c. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
  
ASSIST1d. Methamphetamine (speed, crystal meth, tina, ice, etc.)   
ASSIST1e. Inhalants (poppers, nitrous, glue, gas, paint thinner, etc.)   
ASSIST1f. Sedatives or Sleeping Pills (Valium, Ativan, Xanax, Klonopin, 
Librium, Rohypnol, etc.) 
  
ASSIST1g. Gamma Hydroxybutyrate (GHB)   
ASSIST1h. Ecstasy/MDMA/Molly   
ASSIST1i. LSD/Acid/Mushrooms/PCP (Angel Dust)   
ASSIST1j. Special K (Ketamine)   
ASSIST1k. Street opioids (heroin, opium, etc.)   
ASSIST1l. Prescription opioids (morphine, codeine, fentanyl, oxycodone 
[OxyContin, Percocet], hydrocodone [Vicodin], methadone, 








In the past three months, how often have you used the substances you mentioned? 
[DISPLAY ASSIST2a to ASSIST2l IF ASSIST1a,l,… = A] 
 Never Once 
or 
twice 




ASSIST2a. Cannabis (marijuana, pot, grass, 
hash, etc.) 
     
ASSIST2b. Cocaine (coke, crack, etc.)      
ASSIST2c. Prescription stimulants (Ritalin, 
Concerta, Dexedrine, Adderall, diet pills, 
etc.) 
     
ASSIST2d. Methamphetamine (speed, 
crystal meth, tina, ice, etc.) 
     
ASSIST2e. Inhalants (poppers, nitrous, 
glue, gas, paint thinner, etc.) 
     
ASSIST2f. Sedatives or Sleeping Pills 
(Valium, Ativan, Xanax, Klonopin, Librium, 
Rohypnol, etc.) 
     
ASSIST2g. Gamma Hydroxybutyrate 
(GHB) 
     
ASSIST2h. Ecstasy/MDMA/Molly      
ASSIST2i. LSD/Acid/Mushrooms/PCP 
(Angel Dust) 
     
ASSIST2j. Special K (Ketamine)      
ASSIST2k. Street opioids (heroin, opium, 
etc.) 
     
ASSIST2l. Prescription opioids (morphine, 
codeine, fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], 
methadone, buprenorphine [Suboxone], 
etc.) 
     
 
[DISPLAY ASSIST2Stim IF ASSIST2c = B, C, D, or E] 
ASSIST2Stim. You mentioned that you've used prescription stimulants (Ritalin, Concerta, 
Dexedrine, Adderall, diet pills, etc.) in the last 3 months. 
[DISPLAY ASSIST2Stim1 IF ASSIST2Stim IS DISPLAYED] 




C. Don’t know 
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[DISPLAY ASSIST2Stim2 IF ASSIST2Stim1 = B or C] 
 
 
ASSIST2Stim2. Was it prescribed for you? 
A. Yes 
B. No 
C. Don’t know 
[DISPLAY ASSIST2Stim3 AND ASSIST2Stim4 IF ASSIST2Stim2 = B or C] 
ASSIST2Stim3. Do you ever use MORE of your stimulant medication, that is, take a higher 
dosage, than is prescribed for you? 
A. Yes 
B. No 
C. Don’t know 
ASSIST2Stim4. Do you ever use your stimulant medication MORE OFTEN, that is, shorten 
the time between dosages, than is prescribed for you? 
A. Yes 
B. No 
C. Don’t know 
[DISPLAY ASSIST2Sed IF ASSIST2f = B, C, D, or E] 
ASSIST2Sed. You mentioned that you've used sedatives or sleeping pills (Valium, Ativan, 
Xanax, Klonopin, Librium, Rohypnol, etc.) in the last 3 months. 
[DISPLAY ASSIST2Sed1 IF ASSIST2Sed IS DISPLAYED] 




C. Don’t know 
[DISPLAY ASSIST2Sed2 IF ASSIST2Sed1 = B or C] 
ASSIST2Sed2. Was it prescribed for you? 
A. Yes 
B. No 
C. Don’t know 
[DISPLAY ASSIST2Sed3 AND ASSIST2Sed4 IF ASSIST2Sed2 = B or C] 
ASSIST2Sed3. Do you ever use MORE of your sedatives or sleeping pills, that is, take a higher 




C. Don’t know 
ASSIST2Sed4. Do you ever use your sedatives or sleeping pills MORE OFTEN, that is, shorten 
the time between dosages, than is prescribed for you? 
A. Yes 
B. No 
C. Don’t know 
[DISPLAY ASSIST2PrOpi IF ASSIST2l = B, C, D, or E] 
ASSIST2PrOpi. You mentioned that you've used prescription opioids (morphine, codeine, 
fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine 
[Suboxone], etc.) in the last 3 months. 
[DISPLAY ASSIST2PrOpi1 IF ASSIST2PrOpi IS DISPLAYED] 




F. Don’t know 
[DISPLAY ASSIST2PrOpi2 IF ASSIST2PrOpi1 = B or C] 
ASSIST2PrOpi2. Was it prescribed for you? 
D. Yes 
E. No 
F. Don’t know 
[DISPLAY ASSIST2PrOpi3 AND ASSIST2PrOpi4 IF ASSIST2PrOpi2 = B or C] 
ASSIST2PrOpi3. Do you ever use MORE of your opioid medication, that is, take a higher 
dosage, than is prescribed for you? 
D. Yes 
E. No 
F. Don’t know 
ASSIST2PrOpi4. Do you ever use your opioid medication MORE OFTEN, that is, shorten the 
time between dosages, than is prescribed for you? 
D. Yes 
E. No 





During the past three months, how often have you had a strong desire or urge to use the 
following? 
[DISPLAY ASSIST3a to ASSIST3l IF ASSIST2a,l,… = B, C, D, or E] 
 Never Once 
or 
twice 




ASSIST3a. Cannabis (marijuana, pot, grass, 
hash, etc.) 
     
ASSIST3b. Cocaine (coke, crack, etc.)      
ASSIST3c. Prescription stimulants (Ritalin, 
Concerta, Dexedrine, Adderall, diet pills, 
etc.) 
     
ASSIST3d. Methamphetamine (speed, 
crystal meth, tina, ice, etc.) 
     
ASSIST3e. Inhalants (poppers, nitrous, 
glue, gas, paint thinner, etc.) 
     
ASSIST3f. Sedatives or Sleeping Pills 
(Valium, Ativan, Xanax, Klonopin, Librium, 
Rohypnol, etc.) 
     
ASSIST3g. Gamma Hydroxybutyrate 
(GHB) 
     
ASSIST3h. Ecstasy/MDMA/Molly      
ASSIST3i. LSD/Acid/Mushrooms/PCP 
(Angel Dust) 
     
ASSIST3j. Special K (Ketamine)      
ASSIST3k. Street opioids (heroin, opium, 
etc.) 
     
ASSIST3l. Prescription opioids (morphine, 
codeine, fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], 
methadone, buprenorphine [Suboxone], 
etc.) 






During the past three months, how often has your use of the following substances led to 
health, social, legal, or financial problems? 
[DISPLAY ASSIST4a to ASSIST4l IF ASSIST2a,l,… = B, C, D, or E] 
 Never Once 
or 
twice 




ASSIST4a. Cannabis (marijuana, pot, grass, 
hash, etc.) 
     
ASSIST4b. Cocaine (coke, crack, etc.)      
ASSIST4c. Prescription stimulants (Ritalin, 
Concerta, Dexedrine, Adderall, diet pills, 
etc.) 
     
ASSIST4d. Methamphetamine (speed, 
crystal meth, tina, ice, etc.) 
     
ASSIST4e. Inhalants (poppers, nitrous, 
glue, gas, paint thinner, etc.) 
     
ASSIST4f. Sedatives or Sleeping Pills 
(Valium, Ativan, Xanax, Klonopin, Librium, 
Rohypnol, etc.) 
     
ASSIST4g. Gamma Hydroxybutyrate 
(GHB) 
     
ASSIST4h. Ecstasy/MDMA/Molly      
ASSIST4i. LSD/Acid/Mushrooms/PCP 
(Angel Dust) 
     
ASSIST4j. Special K (Ketamine)      
ASSIST4k. Street opioids (heroin, opium, 
etc.) 
     
ASSIST4l. Prescription opioids (morphine, 
codeine, fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], 
methadone, buprenorphine [Suboxone], 
etc.) 





During the past three months, how often have you failed to do what was normally expected of 
you because of your use of the following substances? 
[DISPLAY ASSIST5a to ASSIST5l IF ASSIST2a,l,… = B, C, D, or E] 
 Never Once 
or 
twice 




ASSIST5a. Cannabis (marijuana, pot, grass, 
hash, etc.) 
     
ASSIST5b. Cocaine (coke, crack, etc.)      
ASSIST5c. Prescription stimulants (Ritalin, 
Concerta, Dexedrine, Adderall, diet pills, 
etc.) 
     
ASSIST5d. Methamphetamine (speed, 
crystal meth, tina, ice, etc.) 
     
ASSIST5e. Inhalants (poppers, nitrous, 
glue, gas, paint thinner, etc.) 
     
ASSIST5f. Sedatives or Sleeping Pills 
(Valium, Ativan, Xanax, Klonopin, Librium, 
Rohypnol, etc.) 
     
ASSIST5g. Gamma Hydroxybutyrate 
(GHB) 
     
ASSIST5h. Ecstasy/MDMA/Molly      
ASSIST5i. LSD/Acid/Mushrooms/PCP 
(Angel Dust) 
     
ASSIST5j. Special K (Ketamine)      
ASSIST5k. Street opioids (heroin, opium, 
etc.) 
     
ASSIST5l. Prescription opioids (morphine, 
codeine, fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], 
methadone, buprenorphine [Suboxone], 
etc.) 





Has a friend or relative or anyone else ever expressed concern about your use of the 
following substances? 












ASSIST6a. Cannabis (marijuana, pot, grass, hash, etc.)    
ASSIST6b. Cocaine (coke, crack, etc.)    
ASSIST6c. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
   
ASSIST6d. Methamphetamine (speed, crystal meth, tina, ice, 
etc.) 
   
ASSIST6e. Inhalants (poppers, nitrous, glue, gas, paint thinner, 
etc.) 
   
ASSIST6f. Sedatives or Sleeping Pills (Valium, Ativan, Xanax, 
Klonopin, Librium, Rohypnol, etc.) 
   
ASSIST6g. Gamma Hydroxybutyrate (GHB)    
ASSIST6h. Ecstasy/MDMA/Molly    
ASSIST6i. LSD/Acid/Mushrooms/PCP (Angel Dust)    
ASSIST6j. Special K (Ketamine)    
ASSIST6k. Street opioids (heroin, opium, etc.)    
ASSIST6l. Prescription opioids (morphine, codeine, fentanyl, 
oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], 
methadone, buprenorphine [Suboxone], etc.) 





Have you ever tried and failed to control, cut down or stop using the following substances? 












ASSIST7a. Cannabis (marijuana, pot, grass, hash, etc.)    
ASSIST7b. Cocaine (coke, crack, etc.)    
ASSIST7c. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
   
ASSIST7d. Methamphetamine (speed, crystal meth, tina, ice, 
etc.) 
   
ASSIST7e. Inhalants (poppers, nitrous, glue, gas, paint thinner, 
etc.) 
   
ASSIST7f. Sedatives or Sleeping Pills (Valium, Ativan, Xanax, 
Klonopin, Librium, Rohypnol, etc.) 
   
ASSIST7g. Gamma Hydroxybutyrate (GHB)    
ASSIST7h. Ecstasy/MDMA/Molly    
ASSIST7i. LSD/Acid/Mushrooms/PCP (Angel Dust)    
ASSIST7j. Special K (Ketamine)    
ASSIST7k. Street opioids (heroin, opium, etc.)    
ASSIST7l. Prescription opioids (morphine, codeine, fentanyl, 
oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], 
methadone, buprenorphine [Suboxone], etc.) 
   
 
ASSIST 8 
Assist8a. Have you ever used any drug by injection (recreational on non-medical use only)? 
A. No, never 
B. Yes, in the past 3 months 
C. Yes, but not in the past 3 months 
[DISPLAY Assist8b IF Assist8a = B] 
Assist8b. In the past 3 months, how often have you injected drugs (recreational on non-
medical use only)? 
A. Once per week or less 




The Alcohol Use Disorder Identification Test (AUDIT) 
The following questions will be about alcohol use and a “standard drink.” A standard drink is 
one 12oz can of beer, one glass of wine, or the equivalent of one shot of hard alcohol. 
AUDIT1. How often do you have a drink containing alcohol? 
A. Never 
B. Monthly or less 
C. 2-4 times a month 
D. 2-3 times a week 
E. 4 or more times a week 
AUDIT2. How many drinks containing alcohol do you have on a typical day when you are 
drinking? 
A. 1 or 2 
B. 2 or 4 
C. 5 or 6 
D. 7 to 9 
E. 10 or more 
AUDIT3. How often do you have six or more drinks on one occasion? 
A. Never 
B. Less than monthly 
C. Monthly 
D. Weekly 
E. Daily or almost daily 
AUDIT4. How often during the last year have you found that you were not able to stop 
drinking once you had started? 
A. Never 
B. Less than monthly 
C. Monthly 
D. Weekly 
E. Daily or almost daily 
AUDIT5. How often during the lastyear have you failed to do what was normally expected 
of you because of drinking? 
A. Never 
B. Less than monthly 
C. Monthly 
D. Weekly 
E. Daily or almost daily 
AUDIT6. How often during the last year have you needed a first drink in the morning to get 
yourself going after a heavy drinking session ?  
A. Never 
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B. Less than monthly 
C. Monthly 
D. Weekly 
E. Daily or almost daily 
AUDIT7. How often during the last year have you had a feeling of guilt or remorse after 
drinking?  
A. Never 
B. Less than monthly 
C. Monthly 
D. Weekly 
E. Daily or almost daily 
AUDIT8. How often during the last year have you been unable to remember what happened 
the night before because of your drinking?  
A. Never 
B. Less than monthly 
C. Monthly 
D. Weekly 
E. Daily or almost daily 
 
AUDIT9. Have you or someone else been injured because of your drinking?  
A. No 
B. Yes, but not in the last year 
C. Yes, during the last year 
AUDIT10. Has a relative, friend, doctor, or other health care worker been concerned about 
your drinking or suggested you cut down? 
A. No 
B. Yes, but not in the last year 

















Feeling nervous, anxious, or on edge?     
Not being able to stop or control worrying?     
Little interest or pleasure in doing things?     




Internalized Homophobia Scale 
 
Instructions: Please read the following statements about being gay or bisexual and indicate 
your level of agreement from strongly disagree to strongly agree. 
 
 Strongly 
Disagree Disagree Agree 
Strongly 
Agree 
IHS1. I often feel it is best to avoid personal or social 
involvement with other gay/bisexual men 1 2 3 4 
IHS2. I have tried to stop being attracted to men in 
general 1 2 3 4 
IHS3. If someone offered me the chance to be 
completely heterosexual, I would accept the chance 1 2 3 4 
IHS4. I wish I weren’t gay/bisexual 1 2 3 4 
IHS5. I feel alienated from myself because of being 
gay/bisexual 1 2 3 4 
IHS6. I wish that I could develop more erotic feelings 
about women 1 2 3 4 
IHS7. I feel that being gay/bisexual is a personal 
shortcoming for me 1 2 3 4 
IHS8. I would like to get professional help in order to 
change my sexual orientation from gay/bisexual to 
straight 
1 2 3 4 
IHS9. I have tried to become more sexually attracted 
to women 1 2 3 4 
IHS10. Most gay/bi men are too promiscuous 1 2 3 4 
IHS11. I think it’s sad when I see older men who still 
go to gay events and haven’t “settled down” with 
someone yet 
1 2 3 4 
IHS12. I think men who are “effeminate” give a bad 
name to other gay/bi men 1 2 3 4 
IHS13. I like to associate with guys who describe 
themselves as “straight-acting” 1 2 3 4 
IHS14. I think it’s important for different gay “scenes” 
to all be represented 1 2 3 4 
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Access To- and Use of GLBT-Affirmative Resources and Policies 
 















GRPVisit1. LGBT community center? A B C D E 
GRPVisit2. LGBT “friendly” health care provider or 
facility? A B C D E 
GRPVisit3. Gay (LGBT) bar or club? A B C D E 
GRPVisit4. Gay Bathhouse? A B C D E 
GRPVisit5. Gay (LGBT) coffee shop or bookstore? A B C D E 
GRPVisit6. LGBT “friendly” place of worship? A B C D E 
GRPVisit7. Any other type of LGBT “friendly” space 
(like an ongoing club/meeting/group)? A B C D E 
 
[DISPLAY GRPVisit7a IF GRPVisit7 = B, C, D, or E] 
GRPVisit7a. Can you tell me a little bit more about this club/meeting/group? 
A. _____________________ 
 
HealthInsurance. Do you have health insurance?  
A. Yes 
B. No 
C. I don’t know 
[IF BYM(Year) > 1991 DISPLAY InsureParent] 
InsureParent. Do you have health insurance from your parents/guardian?  
A. Yes 
B. No 
C. I don’t know 
 
SamSexMarr. Have you had a same-sex marriage (i.e., marriage license), civil union, or 
registered domestic partnership? 
A. Yes 
B. No 
C. No, but I have had a commitment ceremony (but there was no official paperwork 
from a government entity) 
 
PrimCare. Do you have someone that you consider your primary care provider (a doctor)?  
A. Yes 
B. No 
[DISPLAY PrimCareSexMen IF PrimCare = A] 
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PosKnow. How many HIV-positive people do you know? 
A. Drop down 0-90+ 
 
Pre-Exposure Prophylaxis (PrEP) 
 
Instructions: PrEP (pre-exposure prophylaxis) is a new biochemical strategy to prevent HIV infection. 
PrEP involves HIV-negative guys taking anti-HIV medications (for example, Truvada) once a day, 
every day to reduce the likelihood of HIV infection if they were exposed to the virus. PrEP is highly 
effective to reduce the likelihood of HIV infection. 
 
Please note that PrEP is not the same as taking HIV medications for a brief period of time (i.e., 28 
days) after a high risk exposure to HIV through encounters such as being stuck by a contaminated 
needle or having unprotected intercourse. PrEP is intended for regular, long-term use. 
 
HearPrEP. Where did you first hear about PrEP? 
A. As part of this study  
B. As part of my participation in a different research study 
C. Through a news media source 
D. Through a social media source 
E. Through a friend 
F. Through my main partner 
G. Through a casual sex partner 
H. Through a family member 
I. Through a medical provider 
J. Through a community-based agency 
K. Other (Please describe): _______________________ 
L. I don’t remember 
 
PrEPview.  What source has had the biggest influence on your current views about PrEP? 
a. As part of this study  
b. As  part of my participation in a different research study 
c. Through a news media source 
d. Through a social media source 
e. Through a friend 
f. Through my main partner 
g. Through a casual sex partner 
h. Through a family member 
i. Through a medical provider 
j. Through a community-based agency 
k. Other (Please describe): ________________________ 
l. I don’t remember  
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SpokDocPrEP. Have you ever spoken to a medical provider about starting PrEP? 
 
A. No, I have not ever spoken to a provider about starting PrEP 
B. Yes, and we both decided it was a good option for me and I should start PrEP 
C. Yes, and we both decided it might be a good option but to wait before beginning PrEP 
D. Yes, and we both decided it was not a good option for me 
E. Yes, and the provider was not comfortable prescribing PrEP for me 
F. Yes, and the provider thought it was a good option but I chose not to do it 
 
[DISPLAY PrEPNotSpok IF SpokDocPrEP = A] 
 
PrEPNotSpok. What are the reasons you have not yet spoken to a medical provider about 
PrEP? Check all that apply. 
A. I did not know what PrEP was 
B. I am unsure if I am at high enough risk for HIV 
C. I don’t have a way to pay for it 
D. I haven’t don’t have access to a medical provider who will prescribe it  
E. I haven’t seen my medical provider recently 
F. I haven’t told my medical provider that I am gay/bi/trans 
G. I am concerned about talking to my medical provider about my sex life 
H. I am concerned about PrEP side effects 
I. I prefer to use condoms. 
J. Other (Please specify):_____________________________________________ 
 
PrEPCand. Do you believe that you are currently an appropriate candidate for PrEP? 
A. Yes, I am definitely an appropriate candidate for PrEP 
B. Yes, I think I am an appropriate candidate for PrEP 
C. I’m not sure if I am an appropriate candidate for PrEP 
D. No, I don’t think I am an appropriate candidate for PrEP  
E. No, I am definitely not an appropriate candidate for PrEP 
PrEPFav. In general, I would say the people I am close with: 
A. Are in favor of PrEP 
B. Are opposed to PrEP 
C. Are split evenly between being in favor of and being opposed to PrEP 
D. Don’t have strong opinions either way  
E. Don’t really know what PrEP is 
PrEPLike. Research shows that PrEP is at least 90% effective in preventing HIV when taken 
daily. How likely would you be to take PrEP if it were available for free? 
A. I would definitely take it 
B. I would probably take it 
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C. I might take it 
D. I would probably not take it 
E. I would definitely not take it 
PrEPPlan. PrEP is currently available with a prescription from your doctor, and research has 
shown that a majority of insurance companies cover most or all of the costs of PrEP. Do you 
plan to begin PrEP? 
A. Yes, I will definitely begin taking PrEP 
B. Yes, I will probably begin taking PrEP 
C. I’m not sure – I might begin taking PrEP 
D. No, I probably will not begin taking PrEP 
E. No, I definitely will not begin taking PrEP 
 
[DISPLAY PrEPSoon IF PrEPPlan = A or B] 
PrEPSoon. How soon do you plan to begin taking PrEP? 
A. Within the next month 
B. Within the next 2-3 months 
C. Within the next 4-6 months 
D. Within the next 7 months to a year 
E. More than a year from now 
[DISPLAY PrEPReas if PrEPPlan = C, D, or E] 
PrEPReas. What are the reasons you do not intend to begin PrEP? Check all that apply: 
A. I’m not at high enough risk for HIV 
B. I don’t have a way to pay for it 
C. I don’t have access to a medical provider who will prescribe it 
D. I don’t believe it works well enough 
E. I am too concerned about PrEP side effects 
F. I prefer to use condoms 
G. I don’t want people to think I am HIV-positive 
H. I don’t want to risk being stigmatized for taking PrEP 









Instructions: Current guidelines recommend that individuals on PrEP return to a medical 
provider every 3 months for HIV/STI testing, bloodwork, and a new 3-month prescription. 
PrEPComPresc. Suppose that you were interested in getting a new prescription for PrEP – 
do you have or know of a medical provider that you would feel comfortable asking to 
prescribe it for you? 
A. Yes, I definitely have or know of a provider 
B. Yes, I probably have or know of a provider 
C. No, I probably do not have or know of a provider 
D. No, I definitely do not have or know of a provider 
PrEPComRec. Suppose that you were interested in getting a new prescription for PrEP – 
where would you feel most comfortable receiving your PrEP-related medical care and 
prescriptions? 
A. My primary care provider (my regular doctor) 
B. A clinic specializing in HIV-related care (e.g., an HIV clinic) 
C. A clinic specializing in sexual health (e.g., a Planned Parenthood, an STD clinic) 
D. A clinic specializing in LGBT health care 
E. Other (Please specify): ________________ 
AttentionCheck. This question is to check whether you are paying attention. If you are 
reading this, please select “Strongly agree.”  
A. Strongly disagree 
B. Disagree 
C. Agree 




Barriers to PrEP Uptake 
Instructions: For the following list of items, please rate how important they are to you in 
making your decision whether to take, or continue taking, PrEP. 
When thinking about whether to take/continue 
PrEP, how concerned are you about…  






BarrPrEP1. The long-term effects of PrEP on 
my health? 1 2 3 4 
BarrPrEP2. Potential side effects of PrEP? 1 2 3 4 
BarrPrEP3. The possibility that if I were to 
become HIV+, certain medications might no 
longer work or I might be resistant? 
1 2 3 4 
BarrPrEP4. The possibility that PrEP might not 
provide complete protection against HIV? 1 2 3 4 
BarrPrEP5. Having to return for medical check-
ups every 3 months while I am on PrEP? 1 2 3 4 
BarrPrEP6. Bringing up the topic of PrEP with a 
doctor? 1 2 3 4 
BarrPrEP7. Having to talk to a doctor about 
your sex life? 1 2 3 4 
BarrPrEP8. Having to remember to take PrEP 
every day? 1 2 3 4 
BarrPrEP9. Friends finding out that you are on 
PrEP? 1 2 3 4 
BarrPrEP10. Family finding out that you are on 
PrEP? 1 2 3 4 
BarrPrEP11. Sexual partners finding out that 
you are on PrEP? 1 2 3 4 
BarrPrEP12. The way that men on PrEP are 
portrayed in the media? 1 2 3 4 
BarrPrEP13. The way that other gay/bi men talk 
about guys on PrEP? 1 2 3 4 
BarrPrEP14. Listing PrEP as one of your current 
medications during appointments such as at a 
dentist’s or specialist’s office? 
1 2 3 4 
 
BarrPrEPOther. Are there any other factors that you think prevent yourself or other guys 
from getting on PrEP? (Please describe): 
___________________________________________________________________________
__________________________________________________________________________   
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Partner Violence Questionnaire 
Instructions: Intimate relationships are characterized by many different feelings and behaviors. 
Sometimes relationships involve unwanted physical or emotional violence.   
 
In the past five years/12 months has a boyfriend or partner... No Yes 
PartVioRec1. Hit you with fists or an open hand?   
PartVioRec2. Thrown something at you?   
PartVioRec3. Verbally threatened you in any way?   
PartVioRec4. Verbally demeaned you in front of strangers?   
PartVioRec5. Pushed or shoved you?   
PartVioRec6. Forced you to get high or drunk?   
PartVioRec7. Made fun of your appearance?   
PartVioRec8. Forced you to have sex?   
PartVioRec9. Kicked you?   
PartVioRec10. Hit you with an object?   
PartVioRec11. Damaged or destroyed your property?   




Childhood Sexual Abuse 
ChildForce. When you were age 16 or younger, was there ever a time when you were forced 
or frightened by another person to do something sexual with them when you didn’t want to? 
A. Yes 
B. No 
[DISPLAY ForcePartAge, AgeFirstTime, ManyTimes, and MorePersons IF ChildForce 
= A] 
ForcePartAge. The first time that this happened, how old was this partner? 
A. 5+ years younger than I was 
B. Around the same age as I was 
C. 5-9 years older than me 
D. 10+ years older than me 
E. Not sure 
 
AgeFirstTime. How old were you the first time this happened? 
A. Drop down 1-16 
ManyTimes. How many times did this happen before you turned 17? 
A. Text entry 0-999 
MorePersons. Did this ever happen with more than one person? 
A. Yes 
B. No 
HCV Risk Score 
 
Please answer yes or no to the following questions: Yes No 
HCV1. Have you engaged in condomless receptive anal sex (bareback 
bottomed) in the last 6 months?  
  
HCV2. Have you shared anal sex toys (e.g., dildos) with a partner without 
washing it first in the last 6 months? 
  
HCV3. Have you engaged in fisting without the use of a protective glove 
(either as a fister or fistee) in the last 6 months? 
  
HCV4. Have you recreationally (to get high) injected drugs in the last 12 
months? 
  
HCV5. Have you shared a straw to snort drugs in the last 12 months?    
HCV6. Have you had syphilis, genital herpes (outbreak) or 






Multidimensional Scale of Perceived Social Support 
 
Instructions: We are interested in how you feel about the following statements. Read each 

















PerSocSup1. There is a special 
person who is around when I am 
in need.  
1 2 3 4 5 6 
PerSocSup2. There is a special 
person with whom I can share 
my joys and sorrows.  
1 2 3 4 5 6 
PerSocSup3. My family really 
tries to help me.  
1 2 3 4 5 6 
PerSocSup4. I get the emotional 
help and support I need from my 
family.  
1 2 3 4 5 6 
PerSocSup5. I have a special 
person who is a real source of 
comfort to me.  
1 2 3 4 5 6 
PerSocSup6. My friends really 
try to help me.  
1 2 3 4 5 6 
PerSocSup7. I can count on my 
friends when things go wrong.  
1 2 3 4 5 6 
PerSocSup8. I can talk about 
my problems with my family.  
1 2 3 4 5 6 
PerSocSup9. I have friends with 
whom I can share my joys and 
sorrows.  
1 2 3 4 5 6 
PerSocSup10. There is a special 
person in my life who cares 
about my feelings.  
1 2 3 4 5 6 
PerSocSup11. My family is 
willing to help me make 
decisions.  
1 2 3 4 5 6 
PerSocSup12. I can talk about 
my problems with my friends.  






APPENDIX C: INTERVIEW GUIDE  
I want to thank you for taking the time to talk with me today. I really appreciate your 
willingness to speak with me during what I imagine is a stressful time. Receiving an HIV-
positive test result is often a surprise for people, and there are many emotions that you might 
be experiencing right now—anger, fear, sadness, shame, etc. 
Everything we discuss today will be confidential. This phone call will be recorded. 
Later it will be transcribed into text and the recording will be deleted. We’ll probably talk for 
around 30 to 45 minutes and we’ll send you a $40 Amazon gift card for your time.  I’ll send 
it to you as soon as we get off the phone. I’m legally required to tell you that during our 
conversation if you tell me that you plan to hurt yourself or someone else, I will have to break 
confidentiality in order to protect you or someone else.  
 
The goal for this conversation is to learn more about you and your experiences. I 
know that some of these questions might be difficult to talk about. You don’t have to talk 
about anything that you don’t want to. You can just say “pass” and we will move on. We can 
also stop the interview at any time or stop to take a break whenever you need to. I also want 
to make sure that you’re in a place where you can talk openly, and others won’t be around to 
hear you. 
 
• Do you have any questions?  Can we start the interview? 
  
1. First, I want to talk a little bit about the test results you received. The results indicated 
a preliminary positive result and we told you that you needed to get confirmatory 
testing. Have you been able to get that confirmatory testing? 
a. [Probe for specifics.] 
b. [If they have been tested]   
i. Ok great. Can you tell me a little more about it? 
ii. So where did you go to get tested? 
iii. Have you been connected to treatment? 
iv. And how soon after the diagnosis were you able to get connected to a 
treatment provider? 
v. And was there a delay in actually getting treated? Starting 
medications? 
1. About how long have you been taking the meds? 
2. Has your Dr. scheduled a follow up appointment with you? 
vi. Can you tell me more about your experience starting up with treatment 
and care?  
vii. What has been easy? 
viii. What has been difficult? 
c. Do you have a case manager that has been helping you get through this stuff? 
d. [If they haven’t been tested yet]   
i. Can you tell me more about why you haven’t been tested yet?  
ii. Is there someone you could go to get tested?  Do you have a doctor?  Is 
there a place nearby? 
iii. Tell me what you know about them? Do they have a good reputation in 
the community? Would you feel comfortable going to them? 
iv. When do you think that you might go, if at all?   
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v. Are the reasons things like the timing of the appointment, or it’s too 
far, or things like that? 
vi. [Tell them you can provide some referrals to find a provider.] 
  
2. Have you talked to anyone about your result? 
a. Is there someone you trust who you could talk to about your test result?  
b. [If yes] 
i. Who did you tell?  Was it a roommate/friend/partner…? 
ii. Can you tell me about how that went? 
c. [If no] 
i. Do you think you might tell anyone in the future? 
ii. How do you hope that that conversation might go? 
d. In your opinion, what makes a person “safe” to talk to about this? 
   
3. Can you tell me how much you knew about HIV prior to joining this study? 
a. What have you learned since joining the study? 
  
4. Before joining this study, what did you think your HIV status was?   
a. What experiences did you have that led you to think that? 
  
5. Before you tested for HIV with our study, when was the last time you had an HIV 
test? 
a. [If never/more than a year ago]  
i. Had you thought about getting an HIV test before/since then?  
ii. What happened to make you consider being tested?  
iii. What made it difficult for you to get tested? 
b. When you were last tested, what did the counselor tell you about HIV 
prevention? What did they tell you about PrEP? 
c. Where did you get tested? What made you decide to get tested then/there? 
  
6. When was the last time you were tested for STDs other than HIV? 
a. Where did you get tested? What made you decide to get tested then/there? Do 
you remember if you tested positive for any of STDs at that time? What type 
of treatment did you receive, if any? 
b. If never/more than a year ago: Had you thought about getting tested for STDs 
before/since then? What happened to make you consider being testing? What 
made it difficult for you to get tested? 
c. When you got tested for STDs, What did the provider tell you about HIV 
prevention? Did they mentioned PrEP? What did they tell you about PrEP? 
  
7. Have you ever taken PrEP – or pre-exposure prophylaxis (Truvada)? 
a. If yes, can you tell me a little bit about what that was like? When was it, where 
did you go to get it, how did you decide that you wanted to use PrEP, 
why/when did you stop taking it? 
b. If no, have you heard of PrEP before? How much do you know about PrEP? 
Do you know of any places near you that provide PrEP? 
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c. Have you heard anything about side effects or how effective it is or anything 
like that? 
 
8. Do you know what PEP - or post-exposure prophylaxis?  
d. How much do you know about PEP?  
e. Have you ever taken PEP? 
f. Do you know of any places near you that provide PEP? 
g. [If haven’t heard of] PEP is taking pills after being exposed to HIV for a 
month to prevent an HIV infection.  
h. [If yes] Can you tell me a little bit about what that was like? When was it, 
where did you go to get it, how did you decide that you needed to use PEP… 
  
9. Do you have any thoughts about how you might have gotten HIV? 
 
10. So the delivery of HIV test results over the phone is a new thing for the field. How 
did it go for you? 
i. Is there anything you think we could have done better? 
j. Is there anything you’re concerned with about the process? 
 
11. One of the goals of this project is to try to improve HIV prevention and care services. 
You described XYZ problems, what could have been done to make your experience 
better?  
k. What could have been done to solve those problems?  
l. What do you think would help you and other gay men?   
m. What do you think are the problems with the system as a whole?  
n. What do you think would make HIV prevention and care services better or 
more accessible for people like you? 
 
 
